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ABSTRACT
Background: Medication self-management capacity (MMC) is an individual’s cognitive and
functional ability to self-administer a medication regimen as prescribed. Poor MMC is an issue in
older adults often resulting in negative health outcomes and loss of independence. Therefore,
understanding low-income older adults’ capacity to manage their medications may help identify
individuals who are at risk for developing medication mismanagement and guide future
intervention strategies based on individual need to promote safe medication use and healthy aging
in place in the community.
Objectives: 1) To determine the cognitive and physical functional deficiencies in MMC among
low-income older adults, 2) To identify variables that predict deficiencies in MMC in this
population, 3) To determine the impact of using pharmaceutical aids/services on MMC, and 4) To
examine the association between MMC and emergency room (ER) visits.
Methods: This was a cross-sectional study of older adult residents living in low-income housing
buildings served by the RHWP. At a study interview, information on demographics, medical
history, and medication use was collected. MMC was evaluated using the Medication Management
Instrument for Deficiencies in the Elderly (MedMaIDE) tool. Cognitive and functional status,
health literacy and depression symptoms were assessed. ER visits were determined retrospectively
over the last six months Descriptive analyses were performed to identify cognitive and physical
functional deficiencies in MMC. Linear regression analysis was conducted to identify variables
that predict MMC and assess the relationship between MMC and using pharmaceutical aid/service.
Logistic regression analysis was used to examine the association between ER visits and MMC.
Results: A total of 107 participants were included, and 89% were African-American with an
average age of 68.54 years (±7.23). They had an average of 4.92 (±2.85) comorbidities and used
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approximately 8 (±4.12) medications on a regular basis. The mean total deficiency in medication
management was 3 (±2.00) as assessed by MedMaIDE. Lacking medication knowledge was
common among the participants: 69.16% could not name and 46% state the indication of all of
their medications, and 38.32% did not how and when all of their medications should be taken.
When controlling for ADLs and falls, the mean total deficiency score in MedMaIDE increased
among those with an educational level equal to high school or less compared with participants who
had a higher educational level than high school [β=1.32, 1.24, p= 0.0195, 0.0415, respectively],
and participants who reported difficulty reading prescription medication labels or opening
medication bottles compared with those who did not report any difficulties [β=1.18, 1.43, p=
0.0036, 0.0047, respectively]. About 20.56% of participants were receiving assistance with
medications from someone, and 79.44% used at least one pharmaceutical aid/service. However,
receiving assistance with medications and using pharmaceutical aid/service were not significantly
associated with MMC [p= 0.5334, 0.0853, respectively]. The participants reported a total of 23
(21.5%) ER visits within six months. The adjusted model for age, educational level, number of
comorbidities, and ADLs suggested that for every one-unit increase in the total deficiency score,
the odds of ER visits increased by 1.23 (p=0.1809) times.
Conclusion: Many older adults who lived in low-income housing had impaired capacity to manage
their medications independently. They appeared to have inadequate medication knowledge, which
affects their cognitive ability to manage medications. Low educational level and health literacy
and reporting trouble reading labels or opening medication bottles were predictors to deficient
MMC. Future studies are needed to confirm whether or not MMC predicts those who may not
able to remain living independently safely or who may need additional support with medications
to remain independent.
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CHAPTER ONE
INTRODUCTION
1.1 Older Adult Population and Poverty in the United States
In the United States (U.S.), there has been tremendous growth in the older adult population
since the baby boomer generation turned 50 in the mid of 1990s. In addition, advances in medical
care services with increased evidence for using a multiple medication regimen to manage chronic
diseases has contributed to older adults living longer independently with good health status.1
According to a U. S. Census Bureau report, the older adult population age 65 years and older
accounted for approximately 15% (47.8 million) of the total American population in 2015, and the
older adult population increased by 1.6 million since 2014.2 By 2060, older adult population is
expected to represent about 25% (98.2 million) of the total population and 19.7 million of this
number will be people age 85 years and older. This means nearly one in four of the American
residents will fall in this age group in 2060.2, 3
Because of this population level trend, the total dependency and old-age dependency ratios
are estimated to increase. The dependency ratios represent the potential burden of the dependent
population, those under 18 years and those 65 years and over, on those in the working-age
population (18 - 64 years). The total dependency ratio is the sum of youth and old age dependency
ratio, which calculated by dividing the number of people in the dependent age groups (youth or
older adults) by the number in the working-age group and then multiplying by 100.3,4 The total
dependency ratios declined between 1990 and 2010 as the youth dependency ratio declined
because the baby boomer generation reached adulthood. However, the total dependency ratio is
proposed to rise from 59% in 2010 to 65% and 75% by 2020 and 2040 respectively, as the older
adult population and the old-age dependency ratio is continuing to increase.3
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Rapid growth in the older adult population will likely substantially increase the numbers
of low-income older adults. However, the median household income increased between 2015 and
2016 across all age groups and those with householders of 65 and older had median income
increased by 1.5%, from $41,501 in 2015 to $42,113 in 2016. Yet, many older adults live on a
limited income in the U.S. Half of all Medicare beneficiaries had incomes below $26,200 and 25%
had incomes below $15,250 in 2016.5
Policymakers in the U.S. aim to enhance economic security and independence and reduce
poverty rates among older adult people. Therefore, the U.S. Census Bureau created an alternative
measure of poverty, known as the Supplemental Poverty Measure (SPM) to overcome the concerns
that the (traditional) official poverty measure is outdated and does not accurately reflect resident’s
financial resources and geographic variations in housing costs. Unlike the official measure, the
SPM reflects out-of-pocket medical spending including premiums, which is specifically
significant for older adult people, who spend a larger amount of their household incomes on health
care costs than younger people.4,5
In 2017, the poverty threshold was $11,756 for an individual age 65 or older, and the
official poverty rate was 9.2% in the U.S. However, the SPM rate was 14.1% among older adults,
which results in over seven million older adults living below poverty rate based on SPM, compared
to 4.7 million based on the official measure. The higher poverty rate under SPM is mainly because
the SPM takes into account out-of-pocket medical expenses. Under both the official and
supplemental measures, the national estimates of poverty rate among older adult increased with
age and were higher among female, Black and Hispanic groups, and people with relatively poor
health. Figure 1 illustrates the national estimates of poverty rates under both the official measure
and SPM among older people by age subgroup, sex, race, and health status in 2017.5
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Figure 1.1 National Estimates of Poverty Rates Among People Ages 65
Years and Older in 2017
AGE: 65-69 YEARS

2.0 (12.2)
1.4 (8.2)

70-79 YEARS

2.8 (13.3)
1.8 (8.5)

80+ YEARS

2.1 (18.3)
1.3 (11.4)

GENDER: MALE

2.7 (12.2)
1.6 (7.4)

FEMALE

4.2 (15.6)
2.8 (10.5)

RACE/ETHNICITY: WHITE

4.3 (11.4)
2.6 (6.9)

BLACK

1.0 (23.5)
0.8 (18.7)

HISPANIC

1.0 (25.5)
0.7 (17.3)

HEALTH STATUS: EXCELLENT/VERY GOOD

1.8 (9.7)
1.1 (5.7)

GOOD

2.4 (13.8)

1.5 (8.4)
FAIR/POOR

2.8 (20.6)
2.0 (14.6)
0

5

10

15

Supplemental poverty measure, n (%)

20

25

30

Official poverty measure, n (%)

Note: Numbers in millions (%)
Adapted from the Kaiser Family Foundation analysis of current Population survey, 2016-2018 Annual Social and
Economic Supplement.
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As the low-income older population increases, many of them are living in subsidized
housing to overcome the financial burden. The U.S. Department of Housing and Urban
Development (HUD) estimates that nearly 800,000 older adults live in low-income housing
settings and receive federal support to pay the rent.6 Generally, older adults who are eligible for
residing in low-income housings are more likely to have physical and behavioral health issues,
chronic conditions, and report fair or poor health compared to other older population. Moreover,
this population is less likely to have an education beyond high school compared to other older
people in the community. For instance, it has been reported that 40% older adults residing in lowincome housing had limited mobility and are in need of assistance with everyday activities such
as toileting, eating, bathing, and dressing compared to 19% of other older homeowners. Moreover,
one study reported that 66% of low-income older adult residents were overweight or obese and
25% had diabetes.6
1.2 Age-Related Changes in Cognitive and Physical Functional Abilities
Changes or declines in physical functional ability and cognitive function are part of the
aging process.7,8 These age-related changes substantially limit individual ability to perform one or
more essential activities of independent living. Despite this fact, the number of older adults living
in the community with difficulties in hearing, vision, cognition, ambulation, self-care, or
independent living rises with age.1,3 According to the U.S. Census Bureau’s American Community
Survey report (2008-2012), about 38.7% (15.7 million) of older adults reported one or more
disabilities, and those aged 85 or older represented about 25% of them.9 Table 1.1 summarizes the
prevalence of disability among the older adult population in the U.S. by type of disability and age.
Among the older adult population with disabilities, 12.6% of them were living in poverty, and
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older Blacks with the disability had the highest poverty rate (23.7%) compared to other race
groups.9
Table 1.1 Prevalence of Disabilities among American Older Adult Population in 2008-2012 10
Type of Disability
Ambulatory*
Independent living*
Hearing
Cognitive*
Self-care*
Vision

Total
10,467 (66.5)
7,523 (47.8)
6,354 (40.4)
4,529 (28.8)
4,468 (28.4)
3,028 (19.2)

65-74 years
3,696 (63.6)
1,978 (34)
2,030 (34.9)
1,311 (22.6)
1,177 (20.2)
959 (16.5)

Age n (%)
75-84 years
3,861 (65.2)
2,796 (47.2)
2,400 (40.6)
1,655 (28)
1,595 (26.9)
1,075 (18.2)

85+ years
2,911 (72.8)
2,749 (68.7)
1,924 (48.1)
1,562 (39.1)
1,697 (42.4)
994 (24.9)

Note: Numbers in Thousands (%)
* Ambulatory – Having serious difficulty walking or climbing stairs
* Independent living – having a difficulty doing tasks alone, such as visiting a doctor’s office or shopping
* Cognitive – having difficulty remembering, concentrating, or making a decision
*Self-care – having difficulty bathing or dressing

Another way to measure disability is using the ability to perform both basic activities of
daily living (ADLs) such as bathing/showering, getting in/out of bed/chairs, dressing, eating,
walking and using the toilet, and instrumental activities of daily living (IADLs), such as preparing
meals, managing money, shopping for groceries, or managing/taking medication. Indeed, both are
essential for safe independent living. The Medicare Current Beneficiary Survey analysis in 2013
shows that approximately 30% of the beneficiaries in the community sittings reported at least one
limitation ADLs and 12% reported having one or more limitations in IADLs.4
In general, aging is a significant risk factor for cognitive decline including dementia and
mild cognitive impairment (MCI). Dementia is a cognitive condition that is characterized by a
decline in one or more cognitive function such as, loss of memory, attention, or language or
executive functioning.10 Older adults may experience a significant decline in these cognitive
functions that may interfere with independent living, specifically in performing IADLs.7,10 Unlike
dementia, MCI may sometimes interfere with basic activities, but it may not be severe enough to
affect older adults’ ability to perform IADLs. The prevalence of dementia is increasing by age. It
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was estimated that 5% of older adult ages 71 to 79 years had dementia and this number increased
to 24% by ages 80 to 89 years, and 37% by ages 90 years and older. Another study showed that
the prevalence of dementia in Black adults age 71 years and older was about 21% compared with
11% of whites in the same age group. Dementia is more prevalent among females than males, it
affects approximately 16% of older adult females compared to 11% of males.10
Typically, the ability to perform day-to-day activities (ADLs and IDALs) requires a
complex integration of multiple physiological systems such as the psychomotor, musculoskeletal,
and the cardiorespiratory systems. Most of these systems are altered by age and presence of chronic
conditions. In addition, the ability to perform ADLs and IADLs is affected by an individual’s
cognitive ability, specifically executive cognitive function (ECF).7,8 ECF refers to the individual’s
cognitive ability to engage in independent, appropriate, and self-caring behavior that involves
coordination of simple tasks and ideas into more complex ones.7,8 An example of ECF is
coordinating between planning, organizing, and problem-solving activities to perform medication
management/administration, shopping, and dressing. Previous studies found that 40% to 80% of
older adults who had Mini-Mental State Exam (MMSE) scores indicating normal cognitive
function experienced executive cognitive dysfunction.8
Consequently, older adults with physical and cognitive limitations will face challenges that
affected their abilities to live independently in the community. The U.S. Department of Health and
Human Services (HHS) estimates that about 7% of residents who reach the age of 65 will need
some form of long-term care such as community-based long-term services and support (LTSS)
which is mainly covered by Medicaid.1
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1.3 Multimorbidity and Polypharmacy among Older Adults
Multimorbidity has become more prevalent among older adults as life expectancy has been
increasing and the population has aged. Multimorbidity is defined as co-occurrence of two or more
chronic conditions/diseases that are not cured but can be controlled through pharmacological or
non-pharmacological treatments.11,12 In 2008, 67% of Medicare beneficiaries in community
settings reported living with two or more chronic conditions compared to 33% that reported none
or one chronic condition. The prevalence of multimorbidity increased with age from 62% for those
aged 65-74 years to 75.7% for those aged 75-84 years, and to 81.5% for those aged 85 years and
older. Moreover, females had a higher prevalence of multimorbidity among all age groups
compared to males. The most common chronic conditions among community-dwelling older
adults were hypertension (56%), hyperlipidemia (42.8%), and ischemic heart disease (26.6%).11
Specific combinations of chronic diseases are associated with increased risk of disability
and functional limitations, including limitations in physical and cognitive function and
ADLs.11 For example, having a stroke with diabetes, osteoporosis, or hip fracture, visual
impairment with osteoporosis, and heart disease with cancer may lead to increased risk for
disability. While, having a combination of heart failure with chronic obstructive pulmonary
disease, depression, osteoarthritis, or cognitive impairment may lead to an increased risk of
functional impairment.11 Moreover, older adults with multimorbidity are at higher risk of reporting
poor quality of life, polypharmacy, adverse drug events, and other adverse outcomes such as
hospitalization and death.11,12
As the number of people with multimorbidity increases substantially with age,
polypharmacy is often prevalent and unavoidable among the older adult population. There is
growing evidence for using a multi-drug regimen to manage and control chronic diseases. For
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example, a 79 year old woman with osteoporosis, osteoarthritis, type 2 diabetes, hypertension, and
chronic obstructive pulmonary disease may require up to 12 medications and 19 doses scheduled
in five different times daily based upon clinical practice guidelines.12 In the U. S., older adults are
the major consumers of prescription drugs, accounting for about 34% of pharmacy expenditures.
A recent Centers for Disease Control and Prevention (CDC) report showed that approximately
89% of community-dwelling older adults reported using at least one prescription medication in the
last 30 days, whereas almost 67% reported using three or more, and 50% reported using five or
more prescription medications.13
Although using multiple-medication regimens is an important health intervention to
manage multimorbidity, polypharmacy may cause or contribute to potential negative
consequences, especially among older adults who live independently in the community. Unlike
hospitals or nursing homes, older adults in the community often do not receive needed support or
help from family members, caregivers, or professionals to prevent the potential consequences of
medication misuse/mismanagement. This results in an increased risk of unintentional medicationrelated problems which can lead to serious consequences, such as nonadherence, hospitalization,
emergency room (ER) visits, and a loss of independence.16-18
1.4 Medication-Related Problems among Older Adults
Medication nonadherence is one of the significant health problems among all age groups
in terms of healthcare cost and utilization. Medication nonadherence is contributing to more than
$100 billion in costs to the U.S. healthcare system annually and it is associated with more than
125,000 deaths per year.14 Although using complex and multiple medication regimens to manage
chronic diseases has been recommended by most current clinical guidelines, such complexity
increases the potential for unintentional medication nonadherence. It has been estimated that more
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than 50% of older adults do not take their prescription medications as prescribed.15 Previous
studies showed that 27% of adverse drug events among older adults were preventable. Among
these preventable events, 20% were related to medication nonadherence. Other studies also found
that approximately 28% of hospital admissions, over 70% of medication-related emergency room
(ER) visits, and 23% of nursing home replacements were secondary to medication
nonadherence.15,16
Research has established that decline in cognitive and physical skills required for optimal
independent medication management can lead to unintentional medication nonadherence and
medication errors.15,17 Many older adults have difficulty opening different types of prescription
medication vials/packages, which is one of the required physical skills for independent medication
management.17,18 In addition to older age, many other factors have been associated with the
inability to open medication containers including Parkinson’s disease, rheumatoid arthritis,
cognitive impairment, and impaired vision. Studies have shown that over 60% of older adults were
unable to break a tablet, about 14% had difficulty opening a screw-top bottle, 45% a flip-top bottle,
21% a blister pack, 24% a Dosett dose administration aid, and 64% a child-resistant bottle.17
Reading or interpreting instructions or labels on medication packaging is one of the
essential cognitive skills for independent medication management.17,18 However, it is not only
older adults with vision impairment who are unable to read instructions on medication packaging.
Even those with corrected vision report the same issue resulting in reduced medication
management ability and adherence. Prior studies reported that self-treatment, lack of coordinated
healthcare, recent hospitalization, impaired cognitive status, low socioeconomic status, and a
complex medication regimen are factors contributing to poor medication self-management
capacity in older adults.19,20
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Despite these facts, the majority of community-dwelling older adults maintain the
responsibility for managing their own medications. One study found that approximately 80% of
community-dwelling older adults were responsible for managing their medications with no or little
help from family members or caregivers while they experience a decline in their physical and
cognitive abilities.20 Moreover, another study showed that only 27% of older adults who had
physical difficulty opening their medication containers were getting assistance with their
medications.17 Consequently, there has been a concern about medication self-management
capacity among older adults because they are commonly using multiple medication regimens while
they experience an age-related decline in their cognitive and physical abilities that are required for
managing medication independently.
1.5 Medication Self-Management Capacity (MCC)
Numerous terms, including medication management capacity and medication selfmanagement/administration skills or capacity, are routinely used in the literature to describe a
person’s ability to take his/her own medications. MMC has been defined as “an individual’s
cognitive and functional ability to self-administer a medication regimen as it has been prescribed.”8
A new conceptual model has defined MMC as, “the extent to which a patient takes medication as
prescribed, including not only the correct dose, frequency, and spacing but also its continued, safe
use over time.”14 According to these two definitions, MMC represents an individual’s ability to
self-administer a medication correctly and safely, when this person has the desire to follow the
medication regimen as prescribed by healthcare providers.
Managing a medication regimen is one of the self-care activities that require a high level
of integration and coordination between cognitive and physical skills. A wide range of cognitive
and physical skills have been identified in the literature as requirements for optimal medication
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management including, but not limited to, correctly identifying medications, opening and
removing the medication from packaging, scheduling the medication regimen, and obtaining
medication from the pharmacy or physician office.8,17 Table 1.2 includes the most frequent skills
assessed by different validated instruments of MMC.
Table 1.2 Most Frequent Skills Assessed by Different Validated Instruments of MMC17
Medication Self-Management Skills*
Physical skills

Cognitive skills














Open medication packaging
Remove medication from packaging
Fill a dose-administration aid (pill box)
Re-cover medication container
Split tablet
Measure a dose of liquid medication
Swallow pills or water
Administer non-oral dosage form
Access pharmacy and/or doctor to obtain
medication








Read standard medication label
Describe indications & dosage regimen of
own medications
Demonstrate setting out 24 hours of
medication
Read and interpret additional instructions
Name and identify all of own medications
Judgment and consequences (e.g. know
what to do in missing a dose situation)
Perform calculations
Differentiate medication by color, size or
shape

* The exhaustive list of medication management skills was reported in a review paper that identifies instruments
used in clinical practice to assess patients’ ability to manage medications.

This study will be guided by the conceptual model of medication self-management.14 This
model provides a better understanding of the tasks associated with the optimal management of
medications and sustaining safe and correct use over time in community settings. The authors of
this model deconstruct medication self-management into a series of six steps that a patient must
perform to successfully manage their medications independently (Figure 1.2). These steps are fill,
understand, organize, take, monitor, and sustain. The authors also highlighted the lack of a
comprehensive measure of MMC that can be used to evaluate the full range of skills required by
patients to successfully manage medication regimens.14
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The term medication adherence is generally used to describe the patient's’ medicationtaking behavior over time. It is defined by the World Health Organization defines medication
adherence as "the degree to which the person’s behavior corresponds with the agreed
recommendations from a health care provider.”21 There are many different factors that affect
medication adherence such as medication factors, patient factors, physician factors, system-based
factors.21,22 Non-adherence behaviors are broadly categorized into two types, intentional and
unintentional non-adherence. Intentional non-adherence occurs when the patients purposely decide
not to take or comply with the medication instructions, despite having the ability to take
medications as instructed. This type of non-adherence is related to patients’ beliefs, attitudes and
expectations that influence patients’ motivation to take and sustain taking medications as
prescribed.21,22 In contrast, unintentional non-adherence occurs due to capacity (i.e. forgetfulness,
vision impairment, and dexterity deficiency) or resources (i.e. problems of accessing prescriptions
or cost) limitations that prevent patients from complying with medication instructions.21,22
Therefore, the current medication adherence measures are often focused on measuring whether
you actually take medications or not. However, medication mismanagement usually occurs
unintentionally by patients due to lack or insufficient skills that are necessary for optimal
medication management regime.14 Therefore, measurements of MMC typically determine factors
of whether or not the patients can manage medications independently.
Assessing older adults’ capacity to manage their medication independently is not routinely
performed in clinical practice. Previous studies used measures of medication adherence such as
self-report, pill count, and pharmacy claims data to evaluate MMC.15, 21 However, measures of
medication adherence provide limited insight on subsequent tasks associated with successful

Page 23 of 155

medication self-management and are generally focused on how often medications are taken or
refilled. On the other hand, evaluating patients’ capacity to manage a medication regimen, using a
standardized MMC assessment tool, provides information about how the medication is taken by
patients (i.e. the accuracy of medication use).15, 21 While several instruments have been developed
to evaluate older adults’ MMC, most were designed to identify cognitive and physical barriers to
safe and accurate medication use. Additionally, there is a variation in medication management
skills that are assessed in these instruments. However, the most frequently assessed skills are
opening and removing the correct dose from medication packaging, reading standard medication
labels, and recalling information, which is not a comprehensive evaluation of MMC.17,18,23
The majority of MMC instruments utilize two types of assessment methods, either using
the patient’s own medications or using simulated medication regimens, each with strengths and
limitations. The simulated approach may help standardize the assessment process and it is useful
when the patient’s own medications are not usually available or the patients are reluctant to bring
in their medications for testing. However, using the patient’s own medications approach is
preferred because it causes less stress on older adults, and it reflects what they do routinely in real
life (home) compared to using an unfamiliar simulated approach.17,18,23
Figure 1.2 Model of Medication Self-Management14
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CHAPTER TWO
LITERATURE REVIEW
Measuring Medication Self-Management Capacity
2.1 Introduction
Managing a medication regimen is one of the self-care activities that is important for safe
and independent living. Patients should have sufficient capacity to self-manage medication to
attain positive outcomes and maintain independence. The capacity of self-managing medication
refers to a patient’s cognitive and physical skills to self-administer medications as prescribed.
Typically, it is a measure of a patient’s ability to follow the prescription directions, when they have
the desire to do so. Whereas medication non-adherence may be a result of intentional or
unintentional factors, this is not the case in medication mismanagement. Poor or limited ability to
manage medications normally occurs unintentionally due to functional limitations, which can be
cognitive, physical or both. This could be a consequence of health deterioration or aging, which
negatively affects individuals’ self-care ability. As the patients’ medical and therapeutic needs
increase, self-care ability decreases.1,2 The importance of assessing patients’ ability to manage
medications, using an objective and validated tool, has been elucidated in the literature. It can be
used as a guide to target medication interventions based on patients’ needs to enhance the correct
and safe use of medications among geriatric patients with chronic diseases. Additionally, it can be
a significant indicator of self-care or cognitive function deficits that lead to loss of independence.15

However, assessing patients’ capacity to manage medications independently is not
routinely performed in clinical practice. Usually, healthcare providers assess a patient’s ability to
manage their medication using professional judgment based on the patient’s medical conditions or
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caregiver report. This method is subjective and biased which may lead to over or under estimating
the patient’s ability to manage medications. Additionally, some health professionals use
medication adherence measures, either subjective or objective, as a proxy for a patient’s ability to
manage medications. Most adherence measures are limited to how often the medications are taken
or refilled rather than how the medications are taken by the patient. Even the use of functional
assessments such as MMSE, ADL, or IADL, which can predict patients’ cognitive or physical
ability, may not necessarily assess the required skills for optimal managing of medications. 2,6
Therefore, there are numerous tools that have been developed to assess patients’ capacity
to manage medications independently. These assessments have been subjected to a varying level
of validity and reliability testing. However, none of the previously published assessment
instruments have been recommended as a gold standard to be used in clinical practice or research
studies. Previous literature reviews identified and evaluated those available instruments assessing
patients’ functional ability to manage medications in outpatient settings.2–5 However, there has
been more recent innovation and expansion in the area of instrument development assessing
patients’ ability to manage medications. There have been newly published instruments that were
not included in previous literature reviews. For this review, the included instruments were limited
to those based on with direct observation.
The aim of this review was to identify the available assessment instruments designed to
assess patients’ ability to manage medications independently and identify reliable and valid tools
that could be used in clinical practice and research. Reviewing the medication management
assessment instruments can help healthcare professionals to select the appropriate tools to be used
based upon the tools’ characteristics and psychometric evaluation of its performance. Assessing
patients’ ability to manage their own medications using a validated instrument may help to identify
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barriers for the appropriate and safe use of medications. Also, it helps to plan the intervention to
enhance their performance and safe use of medications based on the potential needs. This may
ensure that older adult patients are aging safely and independently in their own homes as long as
possible.
2.2 Methods
Literature Search
To review the existing medication management assessment instruments, a comprehensive
literature review was conducted using the following electronic databases: PubMed/MEDLINE,
CINAHL Complete, PsycINFO, Embase, and International Pharmaceutical Abstracts (IPA). A
broad search was conducted due to the lack of a standard definition and terminology of patients’
capacity to self-manage medication in the literature. The relevant published studies were targeted
using combinations of key words and medical subject headings (MeSH) in PubMed. The search
strategies used in the other databases were built to reflect similar keywords and MeSH terms used
in the PubMed search as described in Table 2.1. This review was limited to articles published in
English and after 2009 to capture any tool that were not included in the previous review papers.
The final search strategy was performed in October 2018. Bibliographies of the selected articles
were also screened to identify any other relevant articles.
Review Process
The final search yielded a combined total of 3,856 articles. After eliminating the duplicate
studies (n=1,360), a total of 2,496 articles remained for initial screening by title and abstract. Two
authors (Slattum, P.W. & Badawoud, A.M.) reviewed the titles and the abstracts for all the
retrieved articles independently. The following criteria were used to identify all relevant articles:
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1. Preliminarly study introduced/proposed an assessment instrument developed to assess
patients’ or informal caregivers’ capacity to manage their medication in outpatients or
intend to assess the patients ability to self-manage of medications after hospital
discharge.
2. Assessed the required skills to successfully manage a whole/complete medication
regimen.
3. Discussed the psychometric evaluation of the instrument performance, which may
include reliability, validity, or both data.
4. Provided sufficient required details to be replicable in clinical practice.
Any articles that: 1) were not relevant to the review topic, 2) introduced an assessment
measure for adherence, self-care, disease management, or inpatient self-medication program, 3)
introduced an assessment tool to assess medication management among pediatric patients or
formal caregivers managing the medications of another person, or 4) described a tool to assess
patients’ ability to manage one specific complex dosage forms, such as inhalers, or injectable
medications.
2.3 Results
A total of 16 papers were identified, which corresponded to 4 literature reviews and 12 new
studies. The flow chart in Figure 2.1 illustrates the screening and review process. Of the 16 papers
identified describing development and/or validation of instruments that were designed to assess
patients’ medication management capacity, 26 instruments were identified. While 17 instruments
were obtained from the review papers7–23, 9 were newly published (3 were described in 2 separated
papers) since the published reviews.24–35 These 26 instruments are listed in Table 2.2.
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Characteristics of the Studies
The primary validation study for each instrument is described in Table 2.3, illustrating
instrument name (authors), design, aim, sample and psychometric evaluation. Of the 26 studies
reviewed, 20 were conducted in the U.S., three in Canada, and one each in United Kingdom
(Scotland), Sweden, and South Korea. The design of almost all studies were cross-sectional (25),
except one (DRUGS) which was initially validated in a cross-sectional study then followed by a
prospective study.8 Most of the validation studies included a reasonable sample size of > 30
subjects, except studies with five instruments that assessed small sample sizes (<30) (Home-Rx,
Show Back, Patient’s barriers to compliance, SM Task, S-5).17, 19, 24, 28, 32
Content Validity
Of the 26 studies reviewed, studies with 24 instruments were subjected to some sort of
content. However, the studies with two instruments (Show Back and S-5) reported only content
validity.28, 32 In both studies, the content validity was conducted simply among a panel of experts
and a sample of older adult patients.
Construct Validity
Most of the instruments were designed to assess outpatients’ capacity to take their
medications except two of them (PA and S-5).15, 32 The S-5 and PA instruments were developed
to determine the readiness of hospitalized patients to self-manage their medications before they
were discharged.15, 25 Of the 25 studies, 18 studies included a sample of apparently healthy older
adults with an average age of ≥ 65 years. The other seven studies assessed medication management
capacity among patients with HIV (MMT and MMT-R),22,

23

schizophrenia (MMAA and
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VRAMMA),9,

13

Parkinson’s disease (PillQ),29 stroke (S-5),32 and Alzheimer ’s disease and

dementia (Pillbox Test).27
In 20 studies, the correlation between the subject’s ability to manage medications and
cognitive function was tested in order to validate the ability of the proposed instrument to assess
cognitive medication management skills. In six studies, patients’ performance on ADL, IADL, or
both tests was used to correlate the physical medication management ability with functional status
(DRUGS, HMS, MAT, MedMaIDE, MMT-R, PillQ).7,

8, 10, 11, 16, 23, 29

Additionally, patients’

dexterity of handling medication bottles (RAT) and grip strength (SM Task) were used to correlate
physical function with medication management ability.19, 35 Eight studies examined the correlation
between inability to manage medications independently and both physical and cognitive functional
impairment (DRUGS, HMS, MAT, MedMaIDE, SM Task, MMT-R, PillQ, and RAT).7, 8, 10, 11, 16,
19, 23, 28, 35

These analyses confirm that medication management ability decreases when cognitive

or physical functional status deficits increase.
The significant association between medication management performance and medicationrelated outcomes (e.g. medication adherence, medication related-problems, medication regimen
complexity, and the number of medications taken) was reported in studies with nine instruments.
The association between medication management capacity and self-reported adherence was
assessed in five studies (MMPT, MAI SM task, MMT, and SMAT).12, 14, 19, 22, 33, 34 Objective
measures of medication adherence (e.g. pill count, medication refills) were used to validate two
instruments (MMAA and MedMaIDE).9,16 The performance on the ManageMed instrument was
associated with the number of medications taken; PA instrument was associated with medication
related-problems; SMAT was associated with medication regimen complexity.15, 31, 33, 34
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In studies with five instruments, medication management performance was compared with
other measures of medication management capacity. The performance as measured by the DRUGS
and MMPT instruments was significantly associated with self-reported medication management
capacity.7, 8, 12 The patients’ performance as measured with the PA instrument was compared with
self-medication ability during hospital admission.15 In addition, the comparison between two
objective measures of medication management was reported in primary validation studies with
two instruments, the VRAMMA instrument was compared with MMAA, and Home-Rx was
compared with ManageMed. 13, 31
Reliability
The reliability data was not reported for 14 instruments, while 12 of them were subjected
to some sort of reliability testing (i.e. internal consistency, inter-rater and/or test-retest
reliability).7-10,

16, 20-23, 28, 31, 33-35

Only studies with two instruments reported complete and

acceptable reliability evidence including inter-rater and test-retest reliability, and internal
consistency (MedMaIDE, SMAT).16, 33, 34 Studies with five instruments reported only internal
consistency (MMAA, HMS, MM Test, and RAT).20, 9, 10, 35 All instruments that reported internal
consistency had acceptable Cronbach's alpha coefficient values (i.e. > 0.70), except the HMS
instrument, which had low internal consistency (0.38).10 Show Back and RACT instruments were
subjected to only test-retest reliability.21, 28
Selected Instrument Characteristics
Table 2.2 provides details of each instrument, illustrating its purpose as reported by the
authors, number of items, medication management abilities and skills assessed, scoring scale, and
time for administration. Of the 26 instruments, both validity and reliability data were reported for
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12 instruments,7-10, 16, 20-23, 28, 31, 33-35 two of which tested validity using simply content experts’ and
patients’ opinion (Show Back and S-5).28, 32 Only two instruments had been subjected to content
and construct validity testing as well as full reliability testing (MedMaIDE, SMAT). 16, 33, 34
Almost all the identified instruments (25) were designed as performance-based assessment
tools, where the patients’ medication management skills were observed during face-to-face
interviews.6-28, 31-36 One self-reported instrument was identified where the patients were asked to
describe their medication regimen and colors and shapes of the tablet (PillQ).29, 30 The identified
instruments are categorized according to the administration method used: a) performance-based
instruments using patients’ own medications [5 instruments], b) self-reported instrument using
patients’ own medications [1 instrument], c) performance-based instruments using simulated
medication regimen [14 instruments], d) performance-based instruments using both simulated and
patients’ own medication regimens [4 instruments], e) performance-based instruments using a
pillbox [2 instruments].
The main purpose of almost all of the instruments was to assess older adult patients’ ability
to take medications independently at home,6-14,

16-31, 33-35

except for the PA tool, which was

designed to assist with discharge-planning decisions in hospitals and the S-5 tool used to assess
patients’ readiness to self-medicate after stroke.15, 32 Most of the identified instruments covered
both cognitive and physical abilities to manage medications. 6-12, 14-25, 27, 28, 31-35 There were three
instruments assessing only the cognitive ability to manage medications (VRAMMA, Medi-Cog,
and PillQ).13, 26, 29 Sensorial ability to manage medication was assessed in eight instruments, and
these instruments covered cognitive and physical abilities as well (Patient’s barriers to compliance,
MMEI, MMAA, S-5, MAI, PA, SMAT, Pillbox test).14, 15, 17, 18, 27, 32 -34
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The number of items included in each instrument varied from four to 44 items/questions
and that was based upon the number of medication management skills that were assessed in each
instrument. The medication management skills that were assessed varied per instrument. However,
the most frequently assessed skills were identifying medications by reading the labels or recalling
the name or appearance, opening and removing the correct dose from packaging, reading standard
medication labels, and stating dosing time. In the instruments that used patients’ own medications,
cognitive ability to manage medications was assessed by asking the patients to identify/name all
medications and state why and when each medication is taken. Physical ability was assessed by
asking the patients to open/close medication vials/bottles, and removing the required dose from
packaging. The instruments that used a simulated medication regimen tested patients’ cognitive
ability to manage medications by asking them to read and interpret prescription labels (in standard
font size or in different font sizes) and/or organize a pillbox and perform some simple calculations.
Physical ability was determined by assessing patients’ ability to open/close child-resistant caps
and/or different sizes of vials, and the ability to remove pills from vials. The other instruments
determined the cognitive medication management ability by assessing what the patients knew
about their medications (name, dose, indication, and timing) and assessed physical ability using
standardized kits of prescription vials/bottles. Medi-Cog assesses only the cognitive function as
patients are asked to fill in the correct number of “pills” in the correct compartments of a pillbox
using a paper and pencil.26 In contrast, the Pillbox test assesses both cognitive and physical ability
by requiring patients to read standard prescription labels on five pill bottles containing colored
beads (standard pill size) to fill a weekly pillbox.27 Sensorial ability to manage medication was
assessed primarily by asking patients to distinguish tablets by color and/or shape in all instruments.
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The scoring system varied among instruments, however, most of them utilized the response
format of yes and no (able and unable) and summed up all the yes or no responses at the end of
the assessment. The scoring system was not reported for four instruments (MAI, patient’s barriers
to compliance, SM Task, and RACT)14, 17, 19, 21 The VRAMMA and Pillbox Test had multiple
scoring systems, and the SMAT instrument had five scales, and each one was scored differently.13,
27, 33, 34

The administration time may vary based upon the number of medications the patients were
taking when patients’ own medications were used for testing. Additionally, patients with cognitive
impairment may take a longer time to complete the assessment in all types of instruments. The
administration time was not reported in studies of eight instruments (PillQ, RACT, MMPT,
VRAMMA, ManageMed, SMAT, Medi-Cog, Pillbox Test).12, 13, 21, 26, 27, 29, 31 The administration
time for the instruments that used patients’ own medications ranged from 5 to 45 minutes. Most
instruments that used standardized medication regimens for assessment were reported to take less
than 20 minutes to complete with the exception of the MMAA instrument, which reported 45-60
minutes to complete.9 The instruments assessing medication management skills by using both
patients’ own medications and standardized medication regimen took about 30 minutes to
complete.
2.4 Discussion & Conclusion
Discussion
Recently, the area of developing a standardized instrument to quantify medication selfmanagement capacity has been growing. A number of instruments have been developed to assess
the medication management skills required by patients for safe and accurate use of medications.
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Although some of the instruments identified for this evaluation were reviewed in previous papers,
nine newly published instruments were identified. Most instruments were designed to identify
cognitive and physical barriers to successful medication management. Despite this common
rationale, there was inconsistency among the instruments in the specific skills that should be
assessed. In addition, some of the instruments have not generated reliability evidence and some of
them reported limited evidence of reliability. Because medication management is a complicated
construct involving several skills and behaviors, a wide variety of measurements and comparisons
were used to validate the instruments. Most of the instruments were validated by testing its
association with at least one related construct measure such as cognitive function, ADL, IADL
and/or adherence. Consequently, the evidence is insufficient to recommend a single instrument to
be used in clinical practice or research as a “gold standard.”
Clinical Applicability
Despite this wide range of attempts to develop a reliable and valid instrument assessing
medication management capacity, none of the instruments has enough evidence to be
recommended as a standard measure in clinical practice or research. A couple of earlier reviews
nominated some instruments as promising measures for future studies based on the current
reliability and validity evidence, and/or other characteristics such as length of the instrument,
administration method, scoring system, and skills assessed. However, the recommendations made
in the earlier reviews were inconsistent. Both reviews selected DRUGS, MedMaIDE, and MMAA,
but there was controversy about recommending MMPT, HMS, MAT, MM Test, and MMEI.3,4
Therefore, it is important to propose specific desirable characteristics for a suitable
measurement instrument intended to be used in clinical settings and studies. In Table 2.4, a list of
ideal assessment instrument characteristics was created based on the findings of this review and
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previous reviews. Regardless of the purpose of the instrument, the ideal assessment instruments
share some basic characteristics. In general, the ideal instrument should be valid and reliable,
objective and quantitative, easily administered with an uncomplicated scoring system and provide
clear and interpretable results. In addition, it should be brief, administered in less than 30 minutes
with minimal training and materials. The ideal instrument assessing medication management
should assess both cognitive and physical abilities, but at the same time should not be
overwhelming for the patient (Table 2.4). 2–4
Using the patient’s own medication regimen to assess MMC causes less stress on older
adults (non-threatening), and reflects what they do routinely in real life (home) compared to using
an unfamiliar simulated approach. Sometimes, patients are reluctant to bring their medications for
review, especially older adult patients who may anticipate that poor performance may cause loss
of independence. In contrast, using a simulated medication regimen for assessments needs special
training and preparation of a standardized kit of medication labels and bottles. As a result, those
instruments may not be easily portable. However, it is useful when patients’ medications are not
available, and helps to standardize the assessment process to compare between different groups
and/or changes over time.2,4
Based on the current evidence, several cognitive and physical skills were recommended to
be assessed for successful medication management, regardless of the methods each instrument
uses to assess these skills. The ideal assessment instrument should assess some basic cognitive and
physical tasks required to be performed by patients to manage medications independently in reallife. In terms of cognitive skills, the patients should be able to identify medications by whatever
means (i.e. reading the label or recognize the appearance of medication), state indications, and
describe dosing time and medication instructions. Additionally, knowing how and when to order
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more medications (i.e. refills) was considered one of the basic cognitive skills that should be
assessed by ideal medication management instruments. According to the medication selfmanagement capacity model, the patients should be able to sustain the safe use of medication by
being aware of the ongoing supply of medications.36 However, MedMaIDE is the only instrument
that determines patients’ knowledge of how to get their medications. In term of physical skills,
patients’ ability to open their medication packaging and remove the required doses should be
assessed. Most of the instruments assessed patients’ ability to open child-resistant vials because
they were developed in the U.S. where it is the most common type of packaging in the pharmacy
community.
When managing complex and multiple medication regimens, some assessment measures
require that patients be able to split the tablets and be able to handle and administer non-oral
medications (such as different types of inhalers, injectable medications, eye and ear drops, and
nasal sprays). However, few instruments assessed patients’ ability to manage non-oral dosage
forms and none of the instruments used a standardized method for assessing the required skills to
manage non-oral medications. In addition, dose administration aids such as pillboxes are
commonly used by patients required to take multiple medication regimens. Therefore, when the
patients depend on a pillbox to organize their multi-drug regimens, their skills to correctly organize
and fill the pillbox or use a pillbox filled by a caregiver should be assessed.
Based on this review, instruments utilizing the patients’ own regimen are more applicable
for use in clinical settings. DRUGS and MedMaIDE met most of the proposed characteristics for
ideal instruments designed to assess medication management capacity. In addition, they reflect
what the patients do routinely in real life (at home), do not require special preparation or materials,
and cause less stress on patients compared to using an unfamiliar (simulated) approach.
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MedMaIDE is the instrument that demonstrates the most promise for use in future research studies.
It is the most comprehensive instrument compared to other identified instruments; the items
included in MedMaIDE consolidate the required tasks associated with managing prescription. It is
the only instrument that determines a patient’s knowledge of how to get their medications, and is
not limited to oral medications. In addition, it is reasonable in length, taking approximately 30
minutes to administer.
This literature review has several limitations. This review is limited to English language
publications. In addition, the methodological quality of validation studies was not systematically
assessed or reviewed. The list of the ideal instrument characteristics proposed is somewhat
subjective, however, it was adapted from previous literature. The selection of instruments based
on the proposed criteria is subjective and suited to studies done in clinical settings. There might be
other factors that affect patients’ capacity to manage medication (such as motivation for take
medications, patients’ perception about medication, and financial ability) that are not addressed in
the current tools. These factors were beyond the scope of this review. Finally, only the initial
validation studies were discussed in this review, which might omit some details or validation
evidence studied later by the same group who developed the instrument or another independent
group.
Conclusion
A number of instruments assessing medication management capacity have been published
recently. However, the medication management skills assessed and the methods used to assess
these skills varies between instruments. The majority of available instruments may help to
determine cognitive and physical barriers to safe and accurate medication use, and guide the
interventions based on potential patient needs. DRUGS and MedMaIDE demonstrate the most
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characteristics consistent with the proposed criteria for an ideal instrument designed to assess
medication management capacity that are applicable for clinical use.
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Table 2.1 Search Strategy for Each Database
Databases

PubMed/M
EDLINE

CINAHL
Complete

PsycINFO

Embase

IPA

Research Strategy
(("Self Care"[MeSH] OR "Self Efficacy"[MeSH] OR "Self Administration"[MeSH] OR "Patient
Compliance"[MeSH] OR "self care"[All Fields] OR "Medication Adherence"[MeSH] OR "self
management"[All Fields] OR "self administration"[All Fields] OR "self medication"[All Fields]
OR "self efficacy"[All Fields] OR "patient compliance"[All Fields] OR "medication
adherence"[All Fields]) AND ("prescription"[All Fields] OR "prescriptions"[All Fields] OR
"medication"[All Fields] OR "medications"[All Fields] OR "Medication Therapy
Management"[MeSH] OR "medication management"[All Fields])) AND (“assessment”[ti] OR
“assessments”[ti] OR “assess”[ti] OR “assessing”[ti] OR "validity"[ti] OR "validation"[ti] OR
“validating” [ti] OR "reliability"[ti] OR "Psychometrics"[MeSH] OR "psychometric"[ti] OR
"psychometrics"[ti])
((MH "Self Care+" OR MH "Self Administration+" OR MH "Self Medication" OR "self care" OR
"self efficacy" OR "self administration" OR "patient compliance" OR "medication adherence" OR
"self management") AND (MH "Medication Management" OR MH "Medication Compliance"
OR "prescription" OR "prescriptions" OR "medication" OR "medications" OR "Medication
Therapy Management" OR "medication management")) AND TI (“assessment” OR
“assessments” OR “assess” OR “assessing” OR "validity" OR "validation" OR “validating” OR
"reliability" OR "psychometric" OR "psychometrics")
((IndexTermsFilt: ("Self-Efficacy")) OR (IndexTermsFilt: ("Drug Self Administration")) OR
(IndexTermsFilt: ("Self-Management"))) OR((Any Field: ("self care")) OR (Any Field: ("self
efficacy")) OR (Any Field: ("self administration")) OR (Any Field: ("patient compliance")) OR
(Any Field: ("medication adherence")) OR (Any Field: ("self management"))))
AND(((IndexTermsFilt: ("Prescription Drugs")) OR (IndexTermsFilt: ("Drug Therapy"))) OR
((Any Field: ("prescription")) OR (Any Field: ("prescriptions"))OR (Any Field: ("medication"))
OR (Any Field: ("medications")) OR (Any Field: ("Medication Therapy Management")) OR (Any
Field: ("medication management"))))) AND ((title: ("assessment") OR title: ("assessments")
ORtitle: ("assess") OR title: ("assessing") OR title: ("validity") OR title: ("validation") OR title:
("validating") OR title: ("reliability") OR title: ("psychometric") OR title: ("psychometrics")))
("self care" or "self management" or "self administration" or "self medication" or "self efficacy"
or "patient compliance" or "medication adherence").mp. [mp=title, abstract, heading word, drug
trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,
floating subheading word, candidate term word] AND ("prescription" or "prescriptions" or
"medication" or "medications" or "medication management").mp. [mp=title, abstract, heading
word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name,
keyword, floating subheading word, candidate term word] AND ("assessment" or "assessments"
or "assess" or "assessing" or "validity" or "validation" or "validating" or "reliability" or
"psychometric" or "psychometrics").ti.
(("self care" OR "self efficacy" OR "self administration" OR "patient compliance" OR
"medication adherence" OR "self management") AND ("prescription" OR "prescriptions" OR
"medication" OR "medications" OR "Medication Therapy Management" OR "medication
management")) AND TI (“assessment” OR “assessments” OR “assess” OR “assessing” OR
"validity" OR "validation" OR “validating” OR "reliability" OR "psychometric" OR
"psychometrics")
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Figure 2.1 Screening and Reviewing Process
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Table 2.2 Medication Management Capacity Assessment Instruments
MM
abilities
assessed

HOME–
Rx24,25

To assess
an older adult’s ability to manage medication
routines in the home and to identify at-risk
behaviors by home health occupational
therapists
• Assess different dosage forms

Show Back 28

To assess older adult medication selfmanagement proficiency

20

16

5

+

+

+

+

+

+

1) Identify meds, 2) open bottles/vials, 3) remove
dose from package, 4) state time schedule
1) Identify meds & recall med names, 2) open
bottles/vials & remove dose from package, 3) state
indication, food/water coingestion, and 4) timing
1) Medication knowledge (name all drugs and
describe full regimen including indication, rout of
administration, dose and time)
2) Medication taking ability (filling a glass of water,
sip enough water, open bottles/vials, remove dose
from package, and demonstrate admiration method
for oral and non-oral dosage form)
3) Knowledge about ongoing supplies (identify
existing refills, name of pharmacy or physician
office, and available resources)
knowledge of medications,
Recall information, maniple of medication bottles
and/or syringe (if used by pt), and calculate
medication doses

1) Identifying meds, 2) explaining the indication, 3)
Organizing pillbox, 4) describing the administration
process for injectable and inhaled meds. or pills
requiring cutting, 5) Describing the timing of doses

Time
(mins)#

To identify the deficiencies in older adults’
ability to take their medication at home
 Assess different dosage forms

+

Skills assessed

Scoring
Scale

MedMaIDE16

+

Sensorial

Performance-based instruments use patients’ medication regimen
To examine the patient's capacity to manage
DRUGS7,8
his/her own medication regimen, and
4
+
standardize the brown bag review
To quantify seniors’ ability to take oral
6
MedTake
drugs safely, standardize the brown bag
4
+
review

Physical

Cognitive

Purpose*

# items

Instruments

MM skills assessed

0-100

5-15

0-100

30-45

0-13

30

1-16

30-45

0-100

22
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MM
abilities
assessed

To assess the patient's
functional ability to take medication

5

+

+

SM Task19

To assess patients’ ability to plan medication
& successfully administer a new medication

5

+

+

MM Test20

To assess high-level adaptive functioning in
people with early dementia & MMC

17

+

+

RACT21

To assess patient's capacity to adhere to a
medication regimen before its initiation

11

+

+

MMT22

To assess patients’ ability to comply to antiretroviral medication regimens

20

+

+

MMT-R23

To assess patients’ ability to comply to antiretroviral medication regimens

11

+

+

Ask the patients to clearly describe medications
including doses (mg. or color of tablet) and
medication schedule

+

+

Recall, read small font, differentiate tablets by color
and size, open different sizes of vials and liquid
containers, and interpret instructions
1) Read Rx label, 2) Open and close a child-resistant
& a non-child-resistant vials, 3) remove tablets from
vails, 4) Interpret instruction, & 5) differentiate
tablets by color.
1) Read the Rx label, 2) interpret the Rx instructions,
3) open the pill bottle; 4) cut pills when required, and
5) organize weekly pillbox
1) Identify med, 2) Recall number of pills, 3)
calculate days’ supply, 4) explain med regimen, 5)
know the indication, 6) open vial, 7) remove pills
from the vial, & 8) describe the medication vial
1) Read and interpret Rx & auxiliary labels, 2)
open/close & remove/return pills from vials, 3) what
should be done when missing a dose, or having
adverse effects
1) Organize weekly pillbox, 2) calculate day’s
supply, 3) read and interpret Rx & axillary labels, 4)
what should be done when missing a dose, or having
adverse effects
Same as MMT

Time
(mins)#

MMEI18

Skills assessed

Scoring
Scale

Self-reported instruments use patients’ medication regimen
To assess decline in cognitive functioning
and its impact on ADLs in patients with PD
1
PillQ29,30
by asking patients or caregivers about
+
whether patients can independently manage
their medications
Performance-based instruments use standardized medication regimen
Patient's
To assess functional abilities that can make
barriers to
5
+ +
compliance difficult for the older people
17
compliance

Sensorial

Physical

Cognitive

Purpose*

# items

Instruments

MM skills assessed

0-3

< 10

0-5

<5

< 20

0-46

<5

0-100

15-25

0-10

10
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MM
abilities
assessed

MM skills assessed

Cognitive

Physical

Sensorial

To assess geriatric mental health patients
ability to independently manage medications

4

+

+

+

HMS10

To test older adults’ ability to understand and
implement a routine prescription medication

2

+

+

MAT11

To aid in placement decisions regarding level
of care bases on MMC

10

+

+

MMPT12

To identify visual, physical and cognitive
barriers in MM in older adults
To assess MM skills in patients with
schizophrenia
To quickly determine if someone can handle
a moderately difficult medication routine

5

+

+

4

+

VRAMMA13

1) recall information, 2) describe full regimen, 3)
open/close, 4) remove the dose from vials, 5)
differentiate tablet by color
1) Read Rx labels, 2) comprehend medication
regimen, 3) plan a schedule for meds regimen, 4)
open & close vails, 5) remove dose from vials, 6)
organize pillbox.
1) read Rx labels, 2) comprehend medication
regimen, 3) open & close vails, 4) remove dose from
vials, 5) organize pillbox
1) Read Rx labels, 2) open vials, 3) interpret
medication instruction, 4) calculate days’ supply
1) Read Rx label, 2) interpret medication instruction

1) red Rx label, 2) recall information, 3) open/close
vials, 4) perform calculations, 5) organize pillbox
1) Read Rx labels, 2) recall information, 3) interpret
med instruction, 4) open different vails, 5)
To screen the safety and readiness of selfS-532
16 + + + differentiate tablets by shape, color, & size, 6)
medication after stroke.
describing the administration process for injectable
med (if required)
Performance-based instruments use both standardized & patient’s medication regimens
1) Read Rx & auxiliary labels, 2)open different vails,
To evaluate patients’ knowledge and skills to
3) differentiate tablets by color, 4) name all meds, 5)
MAI14
take medications and identify barriers to
2
+ + +
state indication, 6) duration med should be taken, 7)
optimal MM
state dose and time
ManageMed31

PA15

To identify barriers to medication selfadministration and to assist dischargeplanning decisions in hospital

33

28

+

+

+

+

+

1) Read labels, 2) open vials, 3) remove dose from
vials, 4) differentiate tables by color, 5) organize
pillbox, 6) describe a regimen, & 7) swallow pills

Time
(mins)#

# items

MMAA9

Skills assessed

Scoring
Scale

Purpose*

Instruments

0-25

45-60

0-11

15-30

0-100

5-15

0-5
No
specific
0-42

15-20

Yes-no

4-6

15 –
30

0-28

20
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MM
abilities
assessed

+

13

+

+

3

+

5

+

+

1) Read Rx labels, 2) recall information, 3) interpret
medication instruction, 4) open vials, 5) remove
tablets from packaging, 6) differentiate tablet by
color, & 7) organize pillbox
1) Read Rx labels, 2) open different medication
packaging, 3) manipulate with 5 ml spoon and eye or
ear drop bottles
1) Read Rx labels, 2) interpret medication
instructions, 3) organize pillbox

+

+

1) Read Rx labels, 2) interpret medication
instruction, 3) open vails, 4) differentiate tables by
color, 5) organize pillbox

Time
(mins)#

+

Skills assessed

Scoring
Scale

44

Sensorial

To assess elderly patients' needs for
additional support in managing their
medicines
Performance-based instruments use only pillbox
To assess patients’ ability to fill their own
Medi-Cog26
prescribed medications
into a pillbox
To asses a four compartment of Executive
Pillbox Test27 Function through the real-time assessment of
MM
RAT35

Physical

To screen for MM deficits in older adults &
facilitate targeted interventions

Cognitive

SMAT33,34

Purpose*

# items

Instruments

MM skills assessed

Multiple
scale

0-26

5-20

0-10
No
specific

MM = medication management, Meds = medications, DRUGS = Drug Regimen Unassisted Grading Scale, MedMaIDE = Medication Management Instrument for Deficiencies in the Elderly, HOME–
Rx = In-Home Medication Management Performance Evaluation, PillQ = Pill Questionnaire, MMEI = Medication Management Evaluation Instrument, SM Task = Standardized Medication Task,
MM Test = Medication Management Test, RACT = Regimen Adherence Capability Test, MMT = Medication Management Test, MMT-R = Medication Management Test-Revised, MMAA =
Medication Management Ability Assessment, HMS = Hopkins Medication Schedule, MAT = Medication Administration Test, MMPT = Medication Management Performance Test, VRAMMA =
Virtual Reality Apartment Medication Management Assessment, S-5 = Self-Medication Safety Post-Stroke Scale (S-5), MAI = Medication Assessment Instruments, PA = Pharmacy Assessment,
SMAT = Self-Medication Assessment Tool, RAT = Self-medication Risk Assessment Tool
* Purpose stated as described by the developers
# Reported administration time (minutes)
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Table 2.3 Studies that Introduced a Medication Management Assessment Instrument
Study description
Instruments
(Authors, year)

Design

Aim

Validity
Sample, n

Age,
years
mean
(SD)

Reliability

Content

Construct^

Interrater*

Testretest*

+
(>0.90)

+
(>0.90)

+
(0.74)

+
(0.93)

Internal
consiste
ncy**

Performance-based instruments use patients’ own medications
DRUGS
(Edelberg H.K.,
et al., 1999)
(Edelberg H.K.,
et al., 2000) U.S.

MedTake (Raehl
C.L., et al., 2002)
U.S.

MedMaIDE
(Orwig D., et al.,
2006) U.S.
HOME-Rx
(Bolduc JJ, et al.,
2015)
(Murphy M.C., et
al., 2017) U.S.

Crosssectional
Prospective
cohort

Crosssectional

To introduce DRUGS and examine
the relationship between inability
to take medications and cognitive
impairment

Outpatient
older
adults, 59

84.20
(5.1)

+

Cognitive function
(MMSE)
Functional status
(ADL & IADL)
Self‐reported MMC
Health literacy

To quantify how seniors' ability to
take oral drugs safely may
correlate with age, sex,
socioeconomic status, education,
cognitive impairment, depression,
and drug self-management

Outpatient
older
adults, 57

79.49
(7.26)

+

Cognitive function
(MMSE)
Educational level

78.18
(7.21)

+

Cognitive function
(MMSE)
Functional status
(ADL)
Med. adherence
(pill count)

75.6
(4.4)

+

Cognitive function
(MoCA)
MMC (MangeMed)

76 (7.1)

+

66.4
(7.1)

+

Crosssectional

To describe the MedMaIDE and to
provide results of reliability and
validity testing

Crosssectional

To develop a novel,
performance-based medication
adherence assessment, HOME–Rx

To develop a standardized
simulation to assess MM
proficiency in older adult by home
nurses and test reliability
Self-reported instruments use patients’ own medications
PillQ (Kim J.S.,
CrossTo evaluate the correlation
et al., 2013)
sectional
between ability to MM and
South Korea
Show Back
(Kapoor A., et
al., 2018) U.S.

Crosssectional

Outpatient
older
adults, 50
Communit
y-dwelling
older
adults, 5
Experts, 7
Communit
y-dwelling
older
Adults, 10
Outpatient
with PD,
208

+
(0.71)

+$

Cognitive function
(MMES, MoCA,
CDR)
Page 49 of 155

cognitive functioning in patients
with Parkinson’s disease
Study description
Instruments
(Authors, year)

Design

Aim

Function status
(ADL)
Validity
Sample, n

Performance-based instruments use standardized medication regimen
Patient's barriers
Outpatient
to compliance
CrossTo understand the patient's barriers
older
(Hurd P.D., et at., sectional
to compliance
adults, 14
1986) U.S.
MMEI (Meyer
M.E., et al.,
To develop a simple objective
In &
1989) U.S.
Crossscreening tool that assess the
outpatient
sectional
patient’s functional ability to take
older
medications.
adults, 93

SM Task (Isaac
L.M., et al.,
1993) Canada

Crosssectional

MM Test
(Gurland B.J., et
al., 1994) U.S.

Crosssectional

RACT (Fitten
L.J., et al., 1995)
U.S.

Crosssectional

MMT (Albert
CrossS.M., et al., 1999)
sectional
U.S.

To describe the development of a
method for assessing the
relationship between cognitive
function, comprehension, and
compliance with medication
To measure high-level adaptive
cognitive functioning in early
dementia
To develop an instrument that will
facilitate and focus the assessment
of a patient's capacity to adhere to
a medication regimen before its
initiation
To examine the relationship
between neuropsychological
status, MMT, and antiviral
medication adherence.

Age,
years
mean
(SD)

Content

75.5

+

Age

74.3
(10.1)

+

Cognitive function
(CCSE)

Outpatient
older
adults, 20

71.5
(5.8)

+

Older
adults, 259

Range
(65-85)

+

In &
outpatient
older
adults, 55

69.95
(7.46)

HIVpositive
patients, 61

42.25

Construct^

Reliability
Interrater*

Cognitive function
(neuropsychologica
l battery)
Function status
(grip strength)
Self-reported
adherence
Cognitive function
(CARE)
Dementia diagnosis

Testretest*

Internal
consiste
ncy**

+
(0.82)

+

Cognitive function
(MMES)
Different patients
group

+
(0.70)

+

Cognitive function
(neuropsychologica
l battery test)
Self-reported
adherence

+
(≥0.72)

+
(≥0.74)
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Study description
Instruments
(Authors, year)

MMT-R (Heaton
R.K., et al., 2004)
U.S.

MMAA
(Patterson T.L.,
et al., 2002) U.S.

Design

Crosssectional

Crosssectional

Aim

Validity
Sample, n

Age,
years
mean
(SD)

Content

Construct^

+

Cognitive function
(neuropsychologica
l battery test)
Function status
(IADL)

+

Cognitive function
(neuropsychologica
l battery test)
Adherence
(Pharmacy data)

To evaluate the impact of HIVassociated NP impairment in HIVinfected patients

HIVpositive
patients,
267

To introduce MMAA, and
compare its findings with
adherence

Healthy
participant,
33 vs.
Schizophre
nic
patients.
104

77.5
(2.8)

+

39.32
(7.52)

63.10
(8.8)
56.10
(8.4)

Crosssectional

To develop HMS and validate it

Outpatient
females,
360

MAT (Schmidt
K.S., et al., 2005)
U.S.

Crosssectional

To examine the construct and
concurrent validity of the MAT

Communit
y-dwelling
older
adults, 62

85.56

+

Crosssectional

To uses performance tests of hand
function, vision and medication
competence to assess the
limitations in these dimensions in a
population-based sample of elderly
people

Communit
y-dwelling
older
adults, 492

82.9

+

Self-reported MM

42.1
(10.5)

+

Cognitive function
(neuropsychologica
l battery test)
MMC (MMAA)

76
Range
(47-95)

+

Neurocognitive
function
(Cognistat)

VRAMMA
(Kurtz M.M., et
al., 2007) U.S.

Crosssectional

To validate VRAMMA as a tool
for measuring MM skill in patients
with schizophrenia

ManageMed
(Robnett R.H., et
al., 2007) U.S.

Crosssectional

To introduce ManageMed and
complete initial reliability and

patients
with
schizophre
nia, 25 &
healthy
people, 18
Outpatient
older
adults, 67

Interrater*

Testretest*

Internal
consiste
ncy**

+
(0.96)

+
(0.72)

+
(0.96)

Cognitive function
(MMSE)
Functional status
(IADL)
Cognitive function
(MMSE)
Functional status
(IADL)

HMS (Carlson
M.C., et al 2005)
U.S.

MMPT
(Beckman G.K.,
et al., 2005)
Sweden

Reliability

+
(0.38)

+
(0.860.96)

+
(0.89)
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validity analyses on the
ManageMed Screening
To develop and pilot
Patients
S-5 (Kaizer F., et Crosstest a S-5 to be used in screening
Range
with
al., 2010) Canada sectional
for self-medication safety in
(50-70)
stroke, 6
individuals after stroke
Performance-based instruments use both standardized and patient’s medication regimens
MAI (Murray
To examine the extent and
Outpatient
Cross71.59
M.D., et al.,
correlates of noncompliance in
older
sectional
(9.81)
1986) U.S.
community-dwelling older adults
adults, 140
develop an PA to better
identify drug and patient-specific
PA (Romonko L.,
Hospital
Crossconcerns and to then
et al., 1992)
discharged
80.9
sectional
compare it to
Canada
patients, 51
nursing and medical assessments
utilized in geriatric

SMAT (IrvineMeek J.M., et al.,
2011) Canada

Crosssectional

To evaluate the psychometric
properties, as well as the usability,
of the SMAT, an instrument
designed to measure elderly
patients’ ability to manage their
medications

To determine scale reliability and
validate the instrument against
Crosscommunity pharmacists'
sectional
assessment of patients' ability to
manage their medicines
Performance-based instruments use pillbox
to evaluate the association between
the MMSE,
Medi-Cog
Mini-Cog, MTS, or Medi-Cog
Cross(Anderson K.,
cognitive screens with
sectional
2008) U.S.
patients’ ability to fill their own
prescribed medications
into a pillbox
Pillbox Test
To examine the construct validity
Cross(Zartman A.L.,
of a new measure of EF, the
sectional
2013) U.S.
Pillbox Test which is a real-time
RAT (Lubinga
S.J., et al., 2011)
U.K.

Older
adults
patients,
121

Number of meds
taken
+

+

+

Self-reported
adherence
Self-reported
adherence
Hospital selfmedicated program
Medication-related
problems
Cognitive function
(MMSE, CDT,
CCT)
Medication
regimen
complexity
Self-reported
adherence
Patient’s
comprehension and
dexterity of
handling the
medications

81.5
(7.3)

+

community
dwelling
elderly
patients, 37

Median
= 76
(IQR=7
2, 82)

+

Hospital
discharged
patients, 62

62.5
(13.5)

+

Cognitive function
Correctly filled
pills

Patients
with
Alzheimer’

68.63
(8.08)

+

Executive
Cognitive Function
measures

+
(≥0.79)

+
(≥0.83)

+
(≥ 0.81)

+
(≥0.79)
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assessment of medication
management

s Disease
&
dementia,
40
Healthy
controlled
group, 80

DRUGS = Drug Regimen Unassisted Grading Scale, MedMaIDE = Medication Management Instrument for Deficiencies in the Elderly, MoCA = Montreal Assessment of Cognition, HOME-RX = InHome Medication Management Performance, CDR = Clinical Dementia Rating Scale, CARE= Comprehensive Assessment and Referral Interview. CCSE = Cognitive Capacity Screening
Examination, CDT = Clock Drawing Test, CCT = Cognitive Competency Test , SM Task = Standardized Medication Task, MM Test = Medication Management Test, RACT = Regimen Adherence
Capability Test, MMT = Medication Management Test, MMT-R = Medication Management Test-Revised, MMAA = Medication Management Ability Assessment, PA = Pharmacy Assessment, HMS
= Hopkins Medication Schedule, MAT = Medication Administration Test, MMPT = Medication Management Performance Test, VRAMMA = Virtual Reality Apartment Medication Management
Assessment, S-5 = Self-Medication Safety Post-Stroke Scale, MAI = Medication Assessment Instruments, SMAT = Self-Medication Assessment Tool, RAT = Self-medication Risk Assessment Tool,
MTS = MedicationTransfer Screen
* Reliability coefficient
** Alpha coefficient
^ Significant correlation or association
$ Interrater agreement was reported as κ values for identification (κ = 0.220, 95% CI = −0.142-0.584), explanation (κ = 0.837, 95% CI = 0.627-1.046), organization (κ = 0.840, 95% CI = 0.442 1.229), administration (κ = 0.633, 95% CI = 0.232-1.034), and timing (κ = 0.702, 95% CI = 0.409-0.997)
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Table 2.4 Characteristics for Instruments Assessing Medication Management Capacity
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Open medication packaging
Remove tablets
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* Identify medications by any means such as recalling medication name, distinguishing the appearance, or reading the label
^ Such as, measuring a dose of liquid medication, administering injectable medications, and using inhalers devices
¥ Having complete and acceptable reliability evidence including inter-rater, test-retest reliability and/or internal consistency
§ Reported administration time ≤ 30 minutes

$
£

If required or relevant
Having some sort of construct testing beside simple content validity
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CHAPTER THREE
SPECIFIC AIMS AND SIGNIFICNE
3.1 Hypotheses and Specific Aims
The overall goal of this line of research is to identify older adults living independently in
low-income senior housing who are at risk of losing independence due to medication
mismanagement by screening for medication self-management deficits. This will be achieved by
addressing the following specific aims:
Specific Aim One: To determine the cognitive and physical deficiencies in MMC among older
adults who live in low-income housing.
Hypothesis: A substantial number of older adults who live in low-income housing will have
significant cognitive and physical functional deficiencies in their MMC (low capacity to manage
their medication).
Specific Aim Two: To identify variables that predict low MMC among older adults who live in
low- income housing.
2.1) Assess the relationship between MMC and demographic characteristics.
2.2) Assess the association between MMC and the number of medications and doses that
are taken per day and medication-taking behavior.
2.3) Assess the association between MMC and comorbidities.
2.4) Assess the association between MMC and health literacy, cognitive and functional
status, and depression symptoms.
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Hypothesis: Lower MMC in older adults is associated with increased number of medications and
doses taken daily, increased number of medical conditions, declined in cognitive and functional
status, lower health literacy, and having depression.
Specific Aim Three: To determine the impact of using medication aids and specialized pharmacy
services on MMC, with aids including medication cards/lists, organizers and reminders, and using
specialized medication packaging, easy-to-open containers, large-print labels, medication
synchronization, or prescription home delivery service.
Hypothesis: Using at least one specialized pharmaceutical service will increase the MM score.
Specific Aim Four: To determine the association between MMC and ER utilization over the past
six months in this population.
Hypothesis: Older adults with low MMC will be at a higher risk of using the ER.
3.2 Significance
Living in a low-income community with age-related decline in cognitive and functional
ability coupled with multiple comorbidities increases the demand for community-based long-term
services and support (LTSS). LTSS provides assistance with daily self-care tasks such as eating,
bathing, dressing, managing medication, and preparing meals. It is estimated that 70% of older
adults will need LTSS at some point in their life.1 Problems related to medication mismanagement
are costly and may lead to serious complications such as hospitalization and institutionalization.2,3
In fact, a study on the causes of hospitalization among community-dwelling older adults confirmed
that the risk of hospital and long-term care admissions increased with lack of assistance when
medication support was needed.4 Moreover, the U.S. healthcare system could save as much as $2.6
billion by retaining community-dwelling older adults to age in their homes instead of transferring
them to long-term care facilities.5
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Therefore, understanding the challenges that low-income older adults face during routine
management of medications may help identify targets for future intervention to ensure safe
medication use. This indirectly will promote healthy aging in place and independence in this
population. Consequently, healthcare utilization and the strain on community-based LTSS might
be reduced as well.
This study seeks to identify factors among independently-living low-income older adults
that may predict deficiencies with medication self-management, which could guide future
interventions. First, by exploring the relationship between MMC and various factors, we will help
identify individuals who are at risk for medication mismanagement. Second, determining cognitive
and physical deficiencies in medication management could help healthcare providers (e.g.
pharmacists) identify key targets for intervention strategies based on the individual’s need, to
enhance medication use. For example, providing counseling sessions for older adults who have
limited knowledge about their medications or ordering non-child resistant or specialized packaging
for those who have difficulty opening the bottles of their medication.
In summary, this study seeks to determine the medication self-management capacity
among low-income older adults. In addition, it identifies risk factors that may predict deficiency
in medication self-management capacity among this population, which helps to guide intervention
based on their needs. This study will add evidence for the utility of using a standardized tool to
assess MMC in outpatient settings and ultimately guide interventions to help older adult people to
maintain their independence in their home.
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CHAPTER FOUR
METHODS
4.1 Study Design
This is an observational, cross-sectional study. The study data was collected during a semistructured interview using a battery of assessments. These assessments were selected based upon
the reliability and validity data supporting use in outpatient settings as well as the time required to
be administered. The recruitment, eligibility screening and interviewing was performed by the
study investigator (Amal Badawoud). All assessments were performed by the study investigator
during a scheduled, face-to-face interview with each eligible participant. . The participants were
asked to bring all of their current medication containers (i.e. all medications that they use regularly)
to the interview, including prescription and over-the-counter (OTC) medications, vitamins and
minerals, and dietary supplements (anything they used on a regular basis).
4.2 Study Setting and Participants
This study was conducted in five low-income apartment buildings that are served by the
community-based Richmond Health and Wellness Program (RHWP). These buildings are
designated for low-income people who are aged 55 years and older or individuals with disabilities.
They are located in downtown Richmond, Virginia, and are considered as healthcare “hot spot”
areas where the population lives with a high burden of chronic illnesses, and increased healthcare
utilization such as unnecessary emergency room (ER) visits and ambulance use. Therefore, the
overall goal of RHWP is to reduce unnecessary health care utilization through health and wellness
promotion. It is designed to provide care coordination services to residents, as well as education,
training, and research opportunities for healthcare students. For example, RHWP clinics provide
medication management, geriatric assessments, follow-up and communication with primary care
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providers, and blood pressure and glucose monitoring.1 RHWP is based on a patient-centered care
principle, where residents’ needs determine the care and support provided by an interprofessional
team. The team consists of three to four students ─ from the VCU Schools of Nursing, Pharmacy,
Medicine, Social Work, and the Department of Psychology ─ who are overseen by licensed clinical
faculty. The main goal is to improve residents’ health outcomes, experience with the healthcare
system, and quality of life in order to decrease healthcare costs. At the same time, this practice
also improves students’ performance.1
Approximately 247 residents live in Building 1, 137 live in Building 2, 105 residents live
in Building 3, 77 live in Building 4, and 55 live in Building 5. A total of 348 residents were enrolled
in RHWP from September 2012 through December 2016. The majority of RHWP enrollees are
female (58%), African-American (72%), and with an average age of 74 years. Half of the enrollees
have two or more chronic diseases. Most residents (84.5%) live independently (i.e. do not have
help/aid in the home), and approximately 65% are unable to drive. Most of them use assistive
devices, approximately 36% use a cane, 28% use walker, and 7% are in a wheelchair.1,2
Reviewing residents’ medications is an important service provided by the RHWP. The
most frequent interventions were individualized medication counseling (52%), and medication
management (24.7%).2 Most of RHWP enrollees (90%) are responsible for managing their
medication independently, and approximately 80% of enrollees are responsible for ordering their
medication refills. About 45% of them brought their medications to the RHWP clinics for review.
Residents reported some medication-related issues including having difficulty reading prescription
labels (18%), opening prescription bottles (16%), paying for medications (11%), and getting refills
on time (12%).
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Inclusion and Exclusion Criteria:
Residents living in buildings served by RHWP were recruited for this study based upon the
following criteria: those who were: 1) living in one of the five apartments buildings served by
RHWP, 2) aged 55 years or older, 3) currently taking at least one prescription or over-the-counter
(OTC) medication, 4) living independently, 5) not relying on another person to administer
medications (i.e. family members, friends, or caregivers), 6) able to read and converse in English,
7) not diagnosed with Alzheimer’s disease or dementia, and 8) not taking any medications for
memory such as cholinesterase inhibitors and memantine (i.e. inferred diagnosis of dementia).
Exclusion criteria included participants who were: 1) less than 55 years old, 2) not taking
at least one prescription or OTC medication on a regular basis, 3) fully relying on a caregiver to
administer medications, 4) not able to communicate in English, or 5) reported having a diagnosis
of Alzheimer’s disease or dementia or taking any medication for memory. For example: any
participants taking cholinesterase inhibitors which include donepezil (Aricept®), rivastigmine
(Exelon®), galantamine (Razadyne®, Razadyne ER®); memantine which include (Namenda®,
Namenda Titration Pak®, Namenda XR®, or Namenda XR Titration Pack®); or taking combination
of memantine and Donepezil (Namzaric®) were excluded. The Screening for Eligibility form is in
Appendix 1.
4.3 Recruitment Strategy & Screening for Eligibility
The ideal sampling strategy would be a random selection of residents living in subsidized
housing communities under HUD. However, it would be difficult to access HUD data due to
ethical consideration and privacy concerns and policies to protect privacy, especially for the
vulnerable older adult population. In addition, using this sampling stratgy would be very expensive
and it might take a longer time for recrutiment.
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Therefore, a nonprobability (non-random) sampling strategy, primarily a convenience
sampling technique, was used to recruit the study participants. Convenience sampling is a type of
nonprobability sampling where the target population meets certain predefined criteria, such as easy
accessibility, availability at a specific period of time, or willingness to participate. In other words,
the convenience sample is the population who is easily accessible to the researcher.3 This sampling
technique is convenient, easy, and affordable. Typically, the convenience sample is homogeneous
because they are recruited from one target population. However, the main disadvantage of this
sampling technique is limited generalizability; the results may not be representative of the entire
population.
Furthermore, a snowball sampling technique was used where the study participants were
asked to encourage other people to participate in the study. During the recruitment phase, those
participants who completed the study interview referred their friends and neighbors in the
buildings to participate in the study. Using this sampling technique helps to accelerate the
recruitment process within a short period of time. Like convenience sampling, this sampling
technique may lead to limited generalizability and selection bias.3Several recruitment methods
were used in this study including 1) posting flyers around the apartment buildings and RHWP
clinics, 2) distributing the brochure to residents in all buildings, and 3) introducing the study to
residents during group education sessions given by RHWP providers. The study flyer and brochure
included a brief description of the study and inclusion criteria and contact information for study
investigators. The study recruitment flyer and brochure are in Appendix 2.
In order to partner with the housing buildings and gaining permission to post the study's
flyers and distribute brochures, the study investigators shared the information about the study with
the resident services coordinators at each building. In addition, the study investigators met with
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RHWP clinic staff and discussed the study aims and methods with them to ensure that the conduct
of the study was not disruptive to clinic operations but rather was complementary to the clinic.
These are some of the important factors in successfully carrying out community-based research—
getting buy-in from multiple stakeholders to drive success.
The study investigator was responsible for answering any questions about the study from
the residents who were interested in participating in the study. The contact information of the
investigator was given to the residents who had questions or wanted more information about the
study. After getting all their questions about the study answered, participants signed the screening
consent form. All residents who were interested in the study were screened for eligibility based
on the inclusion criteria. To see if they were eligible to be in this study, they were asked about
their age, medication history, whether they were living independently, able to manage their
medication with no assistance, and whether they had been diagnosed with Alzheimer’s disease,
dementia or memory problems. This screening interview took approximately five minutes or less.
Potential study participants had the option to complete this screening process over the phone or inperson. Both in person and telephone screening consent forms were developed by the investigator
and approved by the VCU Institutional Review Board. The screening consent form included a brief
description of the study, its purpose, voluntary participation, risks and benefits, confidentiality
protections, and HIPAA authorization, as well as the contact information for the study PI. The inperson and telephone screening consent forms are in Appendix 3.
After screening for eligibility, the individual interview was scheduled by the investigator for each
eligible participant. Eligible participants were asked to bring their current medication containers
(i.e. all medications that they use regularly), including prescription and OTC medications, and
vitamins and minerals. In addition, the investigator conducted a day-before reminder phone call
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with eligible participants who provided their phone number. The script for the phone call
reminder/message is in Appendix 4.
4.4 Interview Procedure
The investigator was available in the community area at each resident building during
RHWP clinic hours. Many candidate participants came to the clinic with their medication, ready
for the individual study interview. In this case, the investigator started the interview screening for
eligibility and then proceeded with the study interview. Typically, the study interview procedure
took about 30 to 45 minutes, and not more than 60 minutes. All study interviews took place in a
private area during RHWP clinic hours. At the beginning of the interview, the investigator
completed a Research Subject Information and Consent Form with each eligible participant. The
Research Subject Information and Consent Form is in Appendix 5. Before asking the participant
to provide their signature on the informed consent form, the investigator went over each section in
the consent form with the participants and answered any remaining questions. The informed
consent form was developed by the study investigator. It included detailed information about the
study, its purpose and process, risk and discomfort, benefits, cost and payment process,
confidentiality, voluntary participation and withdrawal, and HIPAA authorization. In addition, it
included the full contact information for the study PI and the office of research at VCU. It was
approved by the VCU IRB. A copy of the full informed consent form was provided for all
participants as a reference for them.
After completing the consent process, the demographic information and medical history were
collected. The participant was then asked to display all medication containers they brought with
them and the investigator gathered all relevant information (see section 4.2 medication list). Using
the complete and comprehensive list of medication taken, a participants’ medication self-
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management capacity was assessed using the Medication Management Instrument for Deficiencies
in the Elderly (MedMaIDE) Tool.6 Following the MMC assessment, participants were asked
questions related to their medication-taking behavior, using medication aids, ordering pharmacy
services, and ER utilization in the last six months. Following that, additional assessments were
administered with the following order: health literacy, cognitive function, functional status, and
depression symptoms. Upon completing all assessments, each participant received $15 cash as
compensation for their time.
4.5 Study Measures
Demographic Characteristics: Each participant was asked about his/her age, sex (male and
female), race (Caucasian, African-American or Black, Hispanic, and Other), marital status (single,
married, separated, divorced, and widowed), educational level (less than high school diploma, high
school graduate/GED, some college, college degree completed), and type of insurance (Medicaid,
Medicare, Dual Eligible, Veteran, other). In addition, the participants were asked to report their
living arrangement (alone, or with other people), as well as how they would rate their health status
in general (excellent, very good, good, fair, poor).
Medical History: The number of comorbidities was recorded using the Functional Comorbidity
Index (FCI). It is a list of 18 clinical comorbidities validated for adjusting the impact of
comorbidity on physical functional status. Participants were asked if they had any of the 18 medical
conditions included in the FCI: arthritis, osteoporosis, asthma, chronic obstructive pulmonary
disease (COPD) (or acquired respiratory distress syndrome (ARDS) or emphysema), angina,
congestive heart failure (or heart disease), heart attack (or myocardial infarction), neurological
disease (e.g., multiple sclerosis or Parkinson’s disease), stroke (or transient ischemic attack (TIA)),
peripheral vascular disease, diabetes types I and II, upper gastrointestinal disease (e.g., ulcer,
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hernia, reflux), depression, anxiety or panic disorders, visual impairment (e.g., cataracts,
glaucoma, macular degeneration), hearing impairment (i.e., very hard of hearing even with hearing
aids), degenerative disc disease (e.g., back disease, spinal stenosis, or severe chronic back pain),
or obesity and/or body mass index (BMI) > 30. The weight in pounds and height in inches were
collected to calculate the BMI. Each listed medical condition is given one point if present and the
final score for the FCI is the sum of all present conditions, which ranges from 0 to 18.4
Medication List: A medication list was created for all medications that were brought by the
participant to the study interview. In the list, the investigator recorded information about each
medication including name (brand or generic), strength, dosage form, dose, the route of
administration, and frequency based upon the label on the medication bottle. The dose and
frequency were not recorded for those prescription medications with a lost or unreadable label. A
total number of medications was calculated as the absolute total count of medications brought by
the participant during the study visit, including prescription and OTC medications,
vitamins/minerals, and dietary supplements as well as as-needed medications (PRN). The number
of daily doses was the count of total doses for these medications except for the PRN medications
doses. For example, two tablets three times per day counted as three doses, regardless of the
number of tablets taken for one medication dose.
Medication Regimen Complexity: The information collected in the medication list was used to
calculate the complexity of the medication regimen for each participant using the Medication
Regimen Complexity Index (MRCI) tool.5 MRCI was selected because it has been widely used in
research studies and validated among older adult patients. It is a reliable and valid tool designed
to quantify the complexity of the prescribed medication regimen based upon the dosage form,
dosing frequency, and the additional administration directions for each medication in the regimen.
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It includes 65 criteria divided into three sections, and each item is assigned a weighted score
corresponding to the relative degree of complexity it adds to the regimen. The first section includes
the weighting score for different dosage forms (e.g. oral: capsules/tablets, liquids, sublingual
sprays/tablets; topical: creams/gels/ointments, patches). The second section represents the
weighting score corresponding to the dosing frequency for each medication in the regimen. The
third section indicates the additional directions if present for each medication. The total MRCI
score is the sum of the scores of the three sections. Since the total MRCI score is based upon how
many prescription medications have been taken by the patient, the minimum total score could be
0 while there is no maximum score.5 In this study, MRC was assessed for only the prescribed
(scheduled and PRN) medications.
Medication Self-Management Capacity (MMC): The Medication Management Instrument for
Deficiencies in the Elderly (MedMaIDE) was used to assess the participants' MMC. It was selected
based upon a comprehensive review conducted to identify the suitable, published MMC
instruments that designed to assess both cognitive and physical ability of older adults to manage
their medications independently. It was the instrument that demonstrates the most promise to be
used in this study. It is a standardized performance-based instrument and has been validated in
outpatient settings. It is the most comprehensive instrument compared to other identified
instruments; the items included in MedMaIDE consolidate the required tasks associated with
managing prescription medication and encompass all six steps of the model of medication selfmanagement. It is the only instrument that determines patient’s knowledge of how to get their
medications, and is not limited to oral medications. In addition, it is short and quick, it takes
approximately 30 minutes to administer.6
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It was developed by a panel of experts in gerontology at the University of Maryland. Previous
research has shown that MedMaIDE is a reliable [test-retest reliability (CC= 0.93), interrater
reliability (CC= 0.74), and internal consistency (Cronbach’s alpha = 0.71)] and valid instrument
for identifying cognitive and functional deficiencies in managing medications among older adults
in home settings using their own medications.6,7 The assessment procedure is based upon
observing the medication-taking ability and assessing the knowledge about the individual’s own
medications. It includes 20 items covering three important areas of medication self-management:
1) medication knowledge, 2) medication-taking ability, and 3) knowledge about the ongoing
supply of medications. This medication knowledge was assessed by asking the person to name all
medications; state when, how, why, and the amount of each medication that should be taken, and
whether he/she can identify any problems after taking the medication. The functional ability was
assessed by asking whether the person is able to fill a glass and sip enough of water to swallow
the pills per dosage and asking them to demonstrate opening medication bottles and counting out
the required number of pills, and asking them how they are supposed to administer their
medications (e.g. pointing to the mouth for inhalers and pills, or describing how to draw up
insulin). The third area assesses whether the person is able to obtain his/her medication and sustain
the use of medications by asking about the existing refills, who to contact to get a new prescription,
and whether or not they have the resources to obtain medications (like transportation).6
Each item scores as 0 (able) or 1 (unable), however, only 13 of the 20 items are scored (Table
4.1). The participant must be able to answer each question correctly for all medications to receive
a score of able = 0. The total deficiency score is the sum of the three deficiency sub-scores. The
maximum total score is 13, with a higher score indicating less ability for medication self-
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management. 6 The non-scored items give more details to determine the overall ability to manage
medication and identify the appropriate intervention to enhance medication use.
Table 4.1 Medication Management Instrument for Deficiencies in the Elderly (MedMaIDE)
Areas
First: Medication knowledge
Second: Medication-taking
ability
Third: Access to ongoing supply
Total deficiency score

Number of
items
8
6

Number of
scored items
5
5

Range of the
scored items
0–5
0–5

6
20

3
13

0–3
0 – 13

After completing the medication list, the participants’ medication bottles were kept
displayed on the table in front of the participant. The lists of active medications and the labels on
the containers were used as a reference for what was reported by the participant. Lexicomp Online
was used as a reference to confirm the indication for any new or unfamiliar medications by the
investigator. Moreover, the participants were encouraged to use their medication bottles any time
to answer any question. The scored questions in the first section were asked for each medication
that was brought to the visit by the patient, including scheduled and non-scheduled medications.
In the second section, if more than one medication was taken, the participant was asked to count
the required number of pills for only one medication, and open the bottle cap for different vial
sizes or different packaging used by the participants. In the third section, the participant was asked
to identify the existing refills for one or two medications and whether they could identify the name
of the pharmacy, physician, or senior medical center from which they receive their medications.
Medication-Taking Behavior: The participants were asked questions related to their medicationtaking behavior. First, the participants were asked whether they have medication adherence
barriers. They were asked to report whether they had trouble reading the prescription labels,
opening any medication bottles, refilling or getting the medication on time, or paying for their
medications.
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Medication nonadherence was assessed using the Self-Rating Scale Item (SRSI). It was
chosen because it is a single item, self-reported medication adherence measure and it is easy to be
administered in outpatient clinical settings. This single question is “thinking about the past four
weeks, please rate your ability to take your medications as prescribed,” using a five-point Likert
scale (Excellent, Very Good, Good, Fair, Poor). This single item measure has been validated
among HIV-infected patients, and has shown a significant positive correlation with other objective
adherence measures. In the validation study, patients who rated their ability as excellent were
considered adherent while all other responses were considered non-adherent. This measure has
been validated using the medication event monitoring system (MEMS) with excellent responses
representing a mean of about 80% adherence on MEMS.8,9
Receiving Assistance with Medications: The participants were asked whether they had someone
reminding them to take their medication, setting up their medications in advance (i.e. setting up a
pillbox), or ordering the refills for them on a regular basis. They were categorized into groups:
receiving assistance and not receiving any assistance.
Pharmaceutical Aids/Services: Participants were asked whether they use any medication aids,
such as a medication list or card, medication organizers (e.g. pill box) or reminders (e.g. calendar,
phone application). Moreover, they were questioned about using any services that are provided
by a pharmacy to help them to take or manage their medication, such as ordering specialized
medication packaging (e.g. bubble packs or unit dose packaging, easy to open containers, large
print label), or using medication synchronization, prescription home delivery or mail order
services. Study participants were categorized into three groups: 1) not using any specialized
services, 2) using one service, and 3) using two or more services.
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Emergency Room Utilization: ER visits were assessed retrospectively over the past six months.
Participants were asked whether they had been in the ER in the last six months, and if yes, how
often. Moreover, the main reason for the ER visit was recorded (medical/health-related problems,
fall-related problems, medication-related problems, or other). Participants were dichotomized into
two groups: not reporting any ER visit, and reporting any ER visit.
Health Literacy: Health literacy was assessed using three brief screening questions. These
questions have been validated to identify patients with limited and adequate health literacy skills.
These questions are 1) how often do you have someone help you read hospital materials? 2) how
often do you have problems learning about your medical condition because of difficulty reading
hospital materials? and 3) how confident are you filling out forms by yourself?
Each question is scored on a five-point Likert scale. The scale for the first and second
questions is Never, Occasionally, Sometimes, Often, and Always. While the scale for the third
question is extremely, Quite a bit, Somewhat, A little bit, Not at all. The maximum total score is
15 and higher scores indicate lower health literacy. Based on prior studies, any participant
reporting a three or greater (i.e. sometimes or somewhat and greater) on any question, was scored
as having inadequate or low health literacy. 10,11 These three questions were suitable to be used in
this study because they were brief and quick, it took less than three minutes, and easy scoring
system.
Cognitive Status: Participants’ cognitive status was assessed using the Mini-Cog tool.12,13 The
Mini-Cog is a quick, validated tool for screening for cognitive deficits in older adults in community
settings. In addition, it has been used in the RHWP clinics to assess residents’ cognitive function.
It is commonly used by pharmacists as screening of dementia within assisted living, long-term
care, and community settings.12 It includes two components: a three-item recall and a clock-draw
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task. During three-item recall, the investigator named three unrelated objects (e.g. village, kitchen,
and baby) and asked the participant to recall them after completing the clock-draw task. For the
clock-draw task, participants were asked to draw the face of a clock, then the hands of the clock
pointing to 10 past 11:00. The maximum score for the Mini-cog is 5 points; one point for each
word recalled correctly and two points for a normal clock drawing. A score of ≥ three represents
participants with unimpaired cognitive function while a score of ≤ two represents participants with
impaired cognitive function.12,13, 14
Functional Status: Functional status was assessed using the Katz Activities of Daily Living
(ADL) Index. It is commonly used in research studies as well as one of the clinical assessments
used in RHWP clinics. The ADL Index is a well-known tool used to evaluate participants’ ability
to perform daily living activities independently, including bathing, dressing, toileting, transferring,
continence, and feeding. Participants responded Yes (independent) or No (dependent) for each one
of the six functions. A score of 6-5 will be reported as full function, 4-3 as moderate impairment,
and ≤ 2 as severe functional impairment.15, 14 Moreover, participants were asked whether they use
assistive devices or wear eyeglasses.
Depression Symptoms: The Geriatric Depression Scale-15 (GDS-15) was used to assess how the
participants felt over the past week. It is a 15-item questionnaire that has been validated in
community settings for screening for symptoms of depression. All questions are in Yes and No
format. A score of 0 to 5 was recorded as normal (no indication of depression) while a score of >
5 indicated depression — which is consistent with previous literature.14 It was selected because it
is short and easy to be administered with easy scoring system as well as it is one of the assessment
tools that used in RHWP clinics.
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4.6 Ethical Consideration
In this study, participants were placed at greater than minimal risk due to the nature of data
collected during the study interview. An expedited review was requested from the Institutional
Review Board (IRB) at Virginia Commonwealth University (VCU). The IRB has approved the
protocol of this study as an expedited study. Furthermore, all study materials including recruitment
brochure and flyer, screening and full informed consent forms, and script for all study measures
were reviewed and approved by the IRB. All participants signed the informed consent form that
includes details about the study and clearly states that participation is voluntary. It also identifies
the study investigator and the study PI. All interviews were conducted in the RHWP clinics in an
assigned private area.
According to the study protocol that has been approved by the IRB, all completed interview
and assessments forms were recorded by ID number, not the participants’ names. The hard copy
of the participants’ data including consent forms, demographics, medical, and medications data
was kept in closed boxes in a secure place with the study PI (Dr. Patricia Slattum) at the VCU
office. All participants’ data was entered into the Research Electronic Data Capture application
(REDCap). It is a secure web application, used to build and manage surveys and databases for
research, and applicable to store any type of data.16 The findings for this study may be presented
at meetings or published in papers, but participants’ identifying information will not be disclosed.
Identifiers were removed from the dataset built in this study, and de-identified data may be used
for other research studies by this study team or another researcher.
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4.7 Statistical Analyses
Descriptive statistics including mean and standard deviation, or frequency and percentage,
where appropriate for all variables are described in the “Study Measures” section. All statistical
analyses were performed using SAS statistical software (version 9.4, SAS Institute, Cary, NC)
with a significance level of 0.05 and two-tailed tests.
Specific Aim One: Descriptive analysis was performed to determine the cognitive and functional
deficiencies in MMC. The total MedMaIDE deficiency score represents the overall deficiency in
MMC for each participant. The first and third areas represent cognitive deficiency while the second
area assesses the functional deficiency in MMC. First, normality for the MedMaIDE sub-scores
for each area and total deficiency score was checked. They were approximately normally
distributed on the histograms. Therefore, the mean and ± standard deviation of MedMaIDE subscores and total score were reported.
Specific Aims Two: Linear regression analyses were conducted to identify variables that are
associated with deficient/low MMC. The MedMaIDE total deficiency score was the outcome
variable and used as continuous. The association between the total deficiency score and all study
variables including demographics, comorbidities, medication-taking behavior, as well as geriatric
assessments variables were tested. To compare the mean total deficiency score with continuous
variables, Pearson’ correlation was used. For categorical variables, two-sample T-test with
dichotomous variables and one-way ANOVA with multi-level variables were used. Recategorizing was performed for some variables to overcome small cell size and unequal variance
issues. Race was re-categorized into white and nonwhite, marital status into never and ever
married, living arrangement into living alone and with another, and health status into
excellent/very good, good, and fair/poor. Moreover, the participants who rated their ability to take
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their medications as prescribed as excellent were recorded as adherent while all other responses
(very good, good, fair, and poor) were recorded as non-adherent. The Pearson’s correlation
coefficient (CC), mean and standard deviation (±SD) with p-value were reported. The mean
difference and 95% confidence interval (CI) were reported for the significant associations.
Linear regression analyses were performed to identify the significant predictors that were
associated with low MedMaIDE total deficiency score. First, all variables were tested using
bivariate linear regression analyses (unadjusted models). These bivariate analyses have been
conducted to check the linear regression model assumptions and build the final adjusted model.
Linear regression assumptions are: 1) all observations are independent, 2) the outcome and the
predictors have a linear relationship (linearity), 3) the residuals have a normal distribution
(normality), and 4) equal variance for all observations (homoscedasticity). Violation of model
assumptions was corrected with transformation or recategorization. Collinearity was checked for
all predicted and outcome variables, and any variable with a high correlation coefficient of 0.8 was
eliminated. Second, all predictor variables were used to build the multiple linear regression model
(adjusted model). The adjusted models were created using backward selection technique with a pto-stay value of 0.25 or less. The backward elimination was began with the least significant
predictor, and the variables were removed one at the time.
Four separate models were created using the technique described. The first model tested
the outcome with demographic characteristics and the second model included the comorbidities.
The third one examined the medication-related variables including number of medications and
daily doses that were taken, medication complexity, and medication-taking behavior. The last one
included the variables for geriatric assessments such as health literacy, cognitive and functional
status, fall, use of assistive devices, and depression symptoms. After completing the four models,
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the significant variables were entered into one model. The parameter estimates, standard errors
(±SE), and p-value were reported for both unadjusted and adjusted models.
Specific Aim Three: Linear regression analyses were conducted to determine the impact of
receiving assistance with medication from someone and using pharmaceutical aids/services on
MMC. The outcome variable was MedMaIDE total deficiency score while receiving assistance
with medications and using medication aids/services were the main explanatory variables. The
variable of receiving assistance with medications from someone was dichotomous (yes or no),
while using pharmaceutical aids/services was three groups (using none, using one, using more than
one).
The association between the total deficiency score and these two variables, were checked
using two-sample t-test and one-way ANOVA. The bivariate models were performed to assess the
linear relationship between these two variables and the MedMaIDE total deficiency score. A
Multiple linear regression model was conducted using all the potential predictors from specific
aim two. Using the same technique used in analyzing specific aim two, the model assumptions
and collinearity were checked. Moreover, the backward selection model was used to build the final
model. The main explanatory variables were kept in all final adjusted model regardless of their
significance (p-value).
Specific Aim Four: The purpose of this analysis was to determine the association between MMC
and ER utilization over the past six months. The dichotomous ER visits variable was the outcome
variable while continuous MedMaIDE total deficiency score was the main explanatory variable.
A descriptive table was created including all study variables, stratified by ER visit groups (not
reporting any ER visit and reporting one or more ER visits). The difference between the two ER
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visit groups was assessed using the Chi-square test or Fisher's exact test when the cell size is small
(≤ 5) for the categorical variables. A two-sample T-test was used for continuous variables.
The association between ER utilization over the last six months (outcome) and MMC was
examined using logistic regression analyses. Univariate logistic regression analysis was performed
to determine the association between the ER visit groups and MedMaIDE deficiency scores, as
well as other potential predictors for ER visits. The logistic regression assumptions were tested
before conducting the adjusted logistic model. The logistic regression assumptions are: 1) the
outcome is a binomial distribution, 2) the mean of the outcome is given by the logistic function
which means continuous variables are equivalent, and all predictors are related to the log odds of
the outcome, 3) the values of the outcome are statistically independent, and 4) there are no
influential points. Collinearity was checked for all predictor and outcome variables, and any
variable with a high correlation coefficient of ≥ 0.8 was eliminated. All potential predictors with
modest association with ER visits (p-value ≤ 0.25) were included in the multiple logistic regression
model. Thereafter, the adjusted model was created using backward selection technique with a pto-stay value of 0.25 or less. The step-wise backward elimination began with the least significant
predictor, and the variables were removed one at a time. The MedMaIDE total score was kept in
the model regardless of its significance. The odds ratio for each level of categorical variables as
well as for continuous variables with 95 % confidence interval (CI) and p-value were reported for
both unadjusted and adjusted models. In addition, the final model fit was evaluated using Hosmer
and Lemeshow Goodness-of-Fit test.
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CHAPTER FIVE
RESULTS
5.1 Descriptive Results
It was initially planned to recruit 25% of the total enrollees belonging to RHWP which
would have been about 87 residents. However, many more residents were screened within three
months (July – August) than originally anticipated (113 residents). During this time period, 109
residents successfully completed the full study interview. The data of 107 participants were
included in the final study analysis as described in Figure 5.1.
Figure 5.1 Process of Recruitment and Screening

113 residents were primarily
screened for eligibility

4 residents did not complete the
study interview because they did
not come back for study interview

109 residents completed the full
study interview

2 residents were excluded after
conducting the study interview
 One resident was 50 years old
 One was using donepezil 5 mg
tablet once daily

107 residents were eligible to be
included in the final study analysis
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In this study, the mean participant age was 68.54 years (±7.23) with a minimum age of 55
and a maximum of 89 years. Most of the participants were African-American (89%) who lived on
their own independently (96%) in one of the five senior low-income housings. About 29% of
participants did not complete high school or GED, 42% completed high school or the GED, and
31.78% had college education. There were 64 participants (59.81%) with dual eligible insurance
coverage by Medicaid and Medicare. Moreover, 14 (13.08%) of participants were covered by
Medicaid alone or other insurance, but not Medicare and 26 (24.30%) had Medicare alone or other
insurance but not Medicaid. While only three participants (2.80%) were not eligible for either
Medicaid or Medicare, they received medical care through a coordinated care program for
uninsured people (Table 5.1).
The mean total functional comorbidities index was 4.92 (±2.85). Arthritis was the most
common comorbidity (61.68%) reported by the participants followed by visual impairment such
as cataracts, glaucoma, and macular degeneration (48.6%), obesity (44.86%) and upper
gastrointestinal disease (42.99%). Table 5.2 summarizes the participants’ medical history
measured by FCI.
During the study interview, the participants brought on average 7.73 (±4.12) medications,
the minimum was one prescription or OTC medication and a maximum of 21 medications. About
73% of them were using five or more prescription medications while 96.26% were using at least
four OTC medications and 88.79% were taking at least one vitamin. The mean total doses that
were taken by the participants was 8.13 (±5.11) per day. The mean score for MRCI was 13.95
(±8.64), with a maximum of 36.50 MRCI score.
Regarding medication adherence barriers, 47 participants (43.93%) reported having at least
one difficulty with their medications such as trouble reading the prescription labels, opening the
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medication bottles, refilling medication on time, or paying for medications. Only 20.56% (22
participants) of the study participants reported receiving assistance with these issues from someone
such as family members, friends, RHWP, or primary care physician (PCP) office. However,
64.49% of participants reported not missing a dose of any of their medications in the last 7 days
and about 42% rated their ability to take their medications during the past 4 weeks as excellent
(Table 5.3). Using medication/drug organizers was the most common medication aid that was used
by the study participants, in particular, 7-day pill box organizers. The second most popular was
having medication lists/cards and the least popular was medication reminders either using calendar
reminders or mobile applications. Thirty-two participants (29.91%) used prescription home
delivery or mail order to fill their medications, while only 26 (24.30%) reported enrolling in
medication synchronization services (Table 5.4).
The health literacy assessment showed that 46 participants (43%) had low or inadequate
health literacy. The Mini-Cog total scores indicated that 33 (30.84%) participants had possible
impaired cognitive function, while the total ADL scores indicated that 26 (24.30%) participants
had moderate to low functional status. The fall rate was 11.21% over the last month. However, the
majority of the participants used eyeglasses 87 (81.31%), either for reading or distance vision, and
almost half (51.40%) were using some sort of assistive devices. About 25% of the participants had
felt depressed over the last week (Table 5.5).
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Table 5.1 Participants’ Demographic Characteristics by MedMaIDE Score
Demographic Characteristics
Age, years (range 55-89)

Data
Pearson
summary, Correlation
mean (±SD) Coefficients
68.54 (7.23)
0.10
Data
summary, Mean (±SD)
N (%)

P-value
0.2917
P-value
0.0774

Age
55 - 64 years old
65 - 74 years old
75 years or older

31 (28.97)
58 (54.21)
18 (16.82)

3.10 (2.23)
2.64 (1.85)
3.83 (1.86)

Female
Male

55 (51.40)
52 (48.60)

3.00 (2.20)
2.94 (1.78)

0.8821

Sex

0.4877

Race
White
Black
Other (1 Hispanic & 2 Native American)
Marital Status
Single (never married)
Married
Separated
Divorced
Widowed
Educational Levels
Less than high school diploma
High school /GED
Some college
College degree graduated
Type of Insurance
Medicaid only
Medicare only
Dual eligible
Other
Living Arrangement
Alone
With other
Health Status
Excellent/Very Good
Good
Fair/Poor

15 (14.02)
89 (83.18)
3 (2.80)

3.00 (2.59)
2.92 (1.89)
4.33 (2.08)

50 (46.73)
2 (1.87)
7 (6.54)
31 (28.97)
17 (15.89)

3.18 (2.23)
2.00 (0.00)
2.71 (1.70)
2.81 (2.01)
2.88 (1.49)

31 (28.97)
42 (39.25)
24 (22.43)
10 (9.35)

3.26 (1.69)
3.48 (2.25)
2.21 (1.77)
1.80 (1.32)

14 (13.08)
26 (24.30)
64 (59.81)
3 (2.80)

2.57 (1.70)
2.81 (1.83)
3.16 (2.16)
2.33 (0.58)

0.8530

0.0145*

0.6675

0.4298
103 (96.26)
4 (3.74)

2.94 (1.99)
3.75 (2.06)

31 (28.97)
37 (34.58)
39 (36.45)

3.00 (1.95)
3.08 (2.14)
2.85 (1.94)

0.8753

* Significant P-value < 0.05
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Table 5.2 Participants’ Medical History (Comorbidity) by MedMaIDE Score
Data
summary,
mean (±SD)
4.92 (2.85)

Pearson
Correlation
Coefficients
0.08

187.81 (44.11)

-0.09

0.3504

Height, Inches (range 53 76)

66.37 (4.02)

-0.04

0.6919

BMI (range 16.74 -50.42)

30.17 (7.39)
Data
summary,
N (%)

-0.06

0.5277

Comorbidities
Comorbidities (FCI) (range 0 – 14)
Weight, pounds (range 100 -313)

Comorbidities
Arthritis
Yes
No
Visual impairment
Yes
No
Obesity/ BMI > 30
Yes
No
Upper gastrointestinal disease
Yes
No
Depression
Yes
No
Diabetes types I and II
Yes
No
Anxiety or panic disorders
Yes
No
Congestive heart failure
Yes
No
Degenerative disc disease
Yes
No
Asthma
Yes
No
COPD or Emphysema
Yes
No

Mean (±SD)

P-value
0.3882

P-value
0.7781

66 (61.68)
41 (38.32)

3.02 (2.03)
2.90 (1.96)
0.1939

52 (48.60)
55 (51.40)

3.23 (2.06)
2.73 (1.92)

48 (44.86)
59 (55.14)

2.81 (2.06)
3.10 (1.95)

0.4590

0.6473
46 (42.99)
61 (57.01)

2.87 (2.17)
3.05 (1.87)
0.2282

41 (38.32)
66 (61.68)

3.27 (2.25)
2.79 (1.82)

36 (33.64)
71 (66.36)

3.00 (1.88)
2.96 (2.07)

0.9182

0.6097
35 (32.71)
72 (67.29)

3.11 (2.39)
2.90 (1.79)
0.6090

34 (31.78)
73 (68.22)

3.12 (2.08)
2.90 (1.97)

32 (29.91)
75 (70.09)

2.62 (2.06)
3.12 (1.97)

0.2423

0.1297
28 (26.17)
79 (73.83)

3.46 (2.38)
2.80 (1.83)

24 (22.43)
83 (77.57)

3.17 (1.81)
2.92 (2.05)

0.5901
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Comorbidities
Peripheral vascular disease
Yes
No
Hearing impairment
Yes
No
Stroke or TIA
Yes
No
Heart attack (MI)
Yes
No
Osteoporosis
Yes
No
Neurological disease
Yes
No

Data
summary,
N (%)

Mean (±SD)

P-value
0.2577

23 (21.50)
84 (78.50)

3.39 (1.90)
2.86 (2.02)
0.1315

22 (20.56)
85 (79.44)

3.54 (2.26)
2.82 (1.91)

21 (19.63)
86 (80.37)

3.81 (2.50)
2.77 (1.81)

12 (11.21)
95 (88.79)

3.17 (1.40)
2.95 (2.06)

0.0314*

0.7219

0.6718
5 (4.67)
102 (95.33)

2.60 (1.95)
2.99 (2.01)

1 (0.93)
106 (99.07)

3.00 (0.00)
2.97 (2.01)

0.9888

* Significant P-value < 0.05
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Table 5.3 Medication-Taking Behavior by MedMaIDE Score
Variables
Number of meds (range 1 – 21)
Number of Rx (range 0 – 19)
Number of OTC (range 0 -10)
Number of vitamins, minerals & supplements
(range 0 – 5)
Number of daily doses (range 0 – 24)
Medication Regimen Complexity (range 2 –
36.50)

Data
summary,
mean (±SD)
7.73 (4.12)
6.92 (3.70)
0.82 (1.60)

Pearson
Correlation
Coefficients
0.18
0.15
0.10

0.64 (0.94)

0.08

0.4411

8.13 (5.11)

0.088

0.3665

13.95 (8.64)

0.11

0.2638

Data
summary,
N (%)
Polypharmacy
4 or less meds
5 or more meds
Medication Adherence Barriers
Trouble Reading Rx labels
Yes
No
Trouble Opening Rx bottles
Yes
No
Trouble Refiling meds on time
Yes
No
Trouble Paying for meds
Yes
No
Medication Non-adherence
Missing a dose of any medication
None
One dose
Two or more doses
Ability to take meds as prescribed
Excellent (adherent)
Not Excellent (Not adherent)

Mean (±SD)

P-value
0.0707
0.1224
0.3263

P- value
0.0610

29 (27.10)
78 (72.90)

2.38 (1.84)
3.19 (2.02)

22 (20.56)
85 (79.44)

4.32 (1.94)
2.62 (1.87)

0.0003*

0.0001*
13 (12.15)
94 (87.85)

4.92 (2.50)
2.70 (1.77)

11 (10.28)
96 (89.72)

2.36 (1.75)
3.04 (2.02)

18 (16.82)
89 (83.18)

2.56 (1.20)
3.06 (2.12)

0.2884

0.1728

0.9189
69 (64.49)
17 (15.89)
21 (19.63)

2.91 (1.93)
3.06 (2.68)
3.10 (1.70)
0.0251*

45 (42.06)
62 (57.94)

2.47 (1.67)
3.34 (2.14)

* Significant P-value < 0.05
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Table 5.4 Receiving Assistance with Medications or Using Pharmaceutical Aid/Service by
MedMaIDE
Data
summary, N
(%)
Receiving assistance with medication form someone
Reminder to take meds
Yes
6 (5.61)
No
101 (94.39)
Setting up meds in advance
Yes
9 (8.41)
No
98 (91.59)
Ordering refills
Yes
12 (11.21)
No
95 (88.79)
Receiving assistance with meds
Yes
22 (20.56)
No
85 (79.44)
Medication aids are used
Medication list/card
Yes
45 (42.06)
No
62 (57.94)
Med/drug organizer
Yes
47 (43.93)
No
60 (56.07)
Type of medication/drug organizer is used, (n=47)
1-day pill box organizer (daily)
2 (4.26)
7-day pill box organizer (weekly)
42 (89.36)
14 –day pill box organizer
2 (4.26)
Dose pill pouch
1 (2.13)
Med/drug reminder
Yes
7 (6.54)
No
100 (93.46)
Type of reminder is used, (n=7)
Calendar
4 (57.14)
Application on your phone
3 (42.86)
Pharmacy services ordered or used
Special packaging (bubble pack)
Yes
7 (6.54)
No
100 (93.46)
Easy to open caps (non-child resistant caps)
Yes
10 (9.35)
No
97 (90.65)
Large print labels
Variables

Mean
(±SD)

P- value

0.0098*
5.00 (2.45)
2.85 (1.68)
0.6162
3.44 (2.92)
2.93 (1.67)
0.2025
2.88 (1.67)
3.67 (1.82)
0.1454
3.68 (2.64)
2.79 (1.77)
0.1010
2.60 (2.02)
3.24 (1.96)
0.5172
2.83 (1.87)
3.08 (2.10)

0.7258
2.71 (1.80)
2.99 (2.02)

0.7258

0.0277*
4.57 (2.44)
2.86 (1.93)
0.3825
3.50 (2.17)
2.92 (1.98)
0.3236
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Yes
No
Medication synchronization
Yes
No
Prescription home delivery (mail order)
Yes
No
Using pharmaceutical aids or Services
None
One aid or service
More than one

1 (0.93)
106 (99.07)

1.00 (0.00)
2.99 (2.00)
0.6760

26 (24.30)
81 (75.70)

3.12 (2.09)
2.93 (1.98)

32 (29.91)
75 (70.09)

3.25 (1.85)
2.85 (2.06)

0.3494

0.2818
22 (20.56)
35 (32.71)
50 (46.73)

3.32 (1.96)
2.54 (1.80)
3.12 (2.13)

* Significant P-value < 0.05

Page 93 of 155

Table 5.5 Geriatric Assessments by MedMaIDE Score

Geriatric Assessments
Health literacy
High/adequate health literacy
Low/inadequate health literacy
Mini-cog: 3-item recall
1 ≤ words
2 ≥ words
Mini-cog: Clock drawing test
Normal
Abnormal
Cognitive status
Possible impairment
No impairment
Functional status (ADL)
Highly independent
Moderate/low independent
Fall in the last month
Yes
No
Using assistive devices
Yes
No
Wearing eye-glasses
Yes
No
Type of eyeglasses, (n=87)
Distance vision only
Reading only
Both
Depression status (GDS-15)
Normal (≤ 5)
Depression (≥ 5)

Data summary,
N (%)

Mean (±SD)

P- value
0.0002*

61 (57.00)
46 (43.00)

2.33 (1.62)
3.83 (2.14)
0.9729

25 (23.36)
82 (76.64)

2.96 (1.88)
2.98 (2.04)

65 (60.75)
42 (39.25)

2.91 (1.97)
3.07 (2.05)

0.6809

0.4088
33 (30.84)
74 (69.16)

3.21 (2.03)
2.87 (1.99)
0.0339*

81 (75.70)
26 (24.30)

2.74 (1.85)
3.69 (2.29)
0.0533

12 (11.21)
95 (88.79

4.50 (2.71)
2.78 (1.82)
0.0210*

55 (51.40)
52 (48.60)

3.40 (2.20)
2.52 (1.66)
0.3503

87 (81.31)
20 (18.69)

2.89 (2.07)
3.35 (1.63)

5 (5.75)
41 (47.13)
41 (47.13)
0.5984
80 (74.77)
27 (25.23)

2.91 (1.93)
3.15 (2.21)

* Significant P-value < 0.05

Page 94 of 155

5.2 Deficiencies in Medication Self-Management Capacity
On average approximately eight (±4.12) medications were brought by the participants for
reviewing during the study interview. The study participants had about three (±2.00) total mean
deficiency score as assessed by MedMaIDE. While some participants had no deficiencies, some
of them recorded as many as 10 deficiencies in their MMC. On MedMaIDE, the first are assesses
medication knowledge (i.e. recalling medication names, indications, and doses), the second area
assesses medication-taking ability (i.e. opening medication vials, removing doses from packaging,
filling a glass of water), and the third area determines patients’ knowledge about ongoing supply
of medications (i.e. identifying refills, having transportation to pharmacy). The mean deficiency
sub-score for the first area was 2.17 (± 1.55). However, the mean sub-score for the second area
was 0.22 (± 0.63) and the third area was 0.58 (± 0.71). Table 5.6 summarizes the MedMaID
deficiencies scores.

In addition, 69.16% of the participants were not able to name their

medications, about 46% did not know the indication, and 38.32% of them could not state the
correct dose or frequency for their medications. Furthermore, 41 participants (38.32%) were not
able to identify the number of refills remaining on the prescription label (Table 5.7).
Table 5.6 MedMaIDE Deficiencies Scores
Mean (±SD)
2.17 (1.55)

Minimum – maximum
0–5

2nd area sub-score

0.22 (0.63)

0–4

3rd area sub-score

0.58 (0.71)

0–3

Total score

2.97 (2.00)

0 – 10

1st

Deficiencies score
area sub-score
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Table 5.7 Medication Management Skills Assessed by MedMaIDE
MedMaIDE items

N (%)

1st area: Deficiency in what should be known about medications
1. Name all medications

74 (69.16)

2. State the time of the day for each medication

41 (38.32)

3. State how the medication should be taken

26 (24.30)

4. State why each medication is taken

50 (46.73)

5. Tell me the amount should be taken each time

41 (38.32)

2nd area: Deficiency in how should medications be taken
1. Fill a glass of water
2. Remove top from the medication container

2 (1.87)
10 (9.35)

3. Count out the required number of pills into hand or cup

1 (0.93)

4. Demonstrate administration of each medication

3 (2.83)

5. Sip enough water to swallow medication

8 (7.48)

3rd area: Deficiency in what should be known to get medication refills
1. Identify existing refills on a prescription
2. Identify who to contact to get a prescription refilled
3. Have resources to obtain the medications

41 (38.32)
8 (7.48)
13 (12.15)

5.3 Predictors for Low MMC
The association between MedMaIDE total deficiency score and the demographic
characteristics were reported in Table 5.1. The mean MedMaIDE total deficiency score was
significantly different across participants’ educational level groups. The participants’ with high
school or less had a significantly higher mean of total deficiency score compared to those who had
some college or graduated from college.
There was a positive linear relationship between the mean total of comorbidities and
MedMaIDE scores, however, this relationship was not statistically significant. Moreover, none of
the comorbidities were associated with MedMaIDE total deficiency scores except stroke or
transient ischemic attack (Table 5.2). Participants’ who did not report stroke had a significantly
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lower mean of total deficiency scores compared with those who reported stroke with a significant
mean difference of - 0.22 (95% CI: -1.44, - 0.99).
There were trends of a positive linear relationship between total deficiency score and
number of medications, total daily doses taken, and medication regimen complexity (Table 5.3).
Therefore, the deficiency in the ability to self-manage medication increases as the number of
medications, daily doses, and medication regimen complexity increased. Moreover, the mean
MedMaIDE total deficiency score was higher among those participants who reported using five or
more medications than those who used four or fewer medications. However, this mean difference
was not statistically significant [mean difference = - 0.81, (95% CI: -1.66, 0.04)].
There was a significant association between MedMaIDE total deficiency score and having
trouble reading prescription labels and opening the medication bottles (Table 5.3). Participants
who reported having trouble reading the labels and opening their medication bottles had
significantly lower ability to manage their medications compared to other participants. The mean
difference of total deficiency score was – 1.70 (95% CI: - 1.59, - 0.80) for those with trouble
reading the labels and – 2.22 (95% CI: - 3.32, - 1.13) for those with trouble opening their
medications bottles. Adherent participants who rated their ability to take their medications in the
last four weeks as excellent had significantly lower total deficiency scores compared to others
[mean difference = - 0.87; 95% CI (- 1.63, - 0.11)].
The mean MedMaIDE total deficiency score was not significantly different between those
who received assistance with medications and those who did not (Table 5.4). However, the total
deficiency score for those participants who had someone reminding them to take their on a regular
basis was significantly higher than those who did not [mean difference = - 2.15; 95% CI (- 3.77, 0.53); p-value = 0.010]. There was no significant association between MedMaIDE total deficiency
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score and using pharmaceutical aids/services except ordering special packaging for medication
(i.e. bubble pack). Participants who reported using bubble pack packaging had a significantly
higher deficiency in their ability to manage their medications compared to others (mean difference
= - 1.71; 95% CI: - 3.23, - 0.19).
Low or inadequate health literacy was significantly associated with higher MedMaIDE
total deficiency score [mean difference = - 1.50; 95% CI (- 2.25, - 0.75); p-value = 0.0002].
Participants’ cognitive function was not significantly associated with total deficiency score on
MedMaIDE while there was a significant association with their functional status as measured by
ADL. The participants who reported full ability to perform activities of daily living had
significantly higher ability to self-manage their medications (mean difference = - 0.95; 95% CI: 1.83, - 0.07). Furthermore, using assistive devices was significantly associated with a higher mean
total deficiency score (mean difference = - 0.88; 95% CI: - 1.63, - 0.14). Participants who reported
falls had a higher mean deficiency score compared with those who did not. However, this was not
statistically significant (mean difference = - 1.72; 95% CI: - 3.47.63, - 0.03). Table 5.5 summarizes
the association between MedMaIDE total deficiency score and Geriatric assessment variables.
In the bivariate analysis, the continuous variable of age was approximately normally
distributed on the histogram and q-q plot for the residual. Therefore, the quadratic and categorical
variables of age were tested, and no forms of age variables were significant. However, the
categorical variable of age was included in the regression models because it showed a modest
association with the outcome (p-value = 0.0719). The bivariate analyses showed that none of the
demographic variables were significantly associated with the mean total deficiency score except
educational level. The mean total deficiency score of MedMaIDE among the participants with an
educational level less than high school was on average 1.46 points, and those with an educational
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level equal to high school or GED was on average 1.68 points higher than those with higher
educational levels (Table 5.8). The adjusted model showed that only education level significantly
predicted the participants’ deficiency in medication management ability when adjusted for age and
race. The mean total deficiency score on MedMaIDE was higher by an average of 1.84 points
among the participants who had less than high school education and by 1.44 points among those
with high school education when age and race were controlled (Table 5.8).
The bivariate analyses showed that the linear relationship between the number of
comorbidities and total deficiency score was not significant. Moreover, only the participants who
had had a previous stroke scored higher by an average of 1.04 points on MedMaIDE compared to
those who did not. The adjusted model indicated that having asthma, stroke, and hearing
impairment were significant predictors for the low ability to self-manage medications. The
MedMaIDE total score increased by approximately one point on average among the participants
with asthma, stroke, or hearing impairment (Table 5.9).
Table 5.10 summarizes the findings of unadjusted and adjusted models for MMC with
medication-taking behavior variables. The unadjusted model suggested that the association
between MedMaIDE total deficiency score and having trouble reading prescription labels or
opening medication containers were significant. Participants who reported having difficulty
reading the labels on the prescription bottles had a higher mean total deficiency score by an average
of 1.70, compared to those who did not. Moreover, those who reported difficulties opening their
medication vials or containers had a higher mean total deficiency score by an average of 2.22
compared to those who did not. Moreover, medication non-adherence, as assessed by asking the
participants to rate their ability to take their medication as prescribed in the last four weeks, was
significantly associated with medication management capacity. Those participants who were not
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adherent had a significantly higher MedMaIDE total deficiency score by an average of 0.87 scores
compared to adherent participants. The adjusted model for medication-taking behavior variables
showed that reporting trouble reading prescription labels and opening medication bottles were
significant predictors for poor medication self-management capacity. The total deficiency score
increased by more than one point on average among the participants who reported difficulty
reading the labels on the prescription bottles and opening the bottles.
In the bivariate analyses, health literacy, ADLs, fall, and using assistive devices were
significantly associated with the mean total deficiency score of MedMaIDE (Table 5.11). The
mean total deficiency score of MedMaIDE increased by 1.50 points among the participants who
had low or inadequate health literacy compared to those who had high or adequate health literacy.
Compared to those participants who were fully independent as assessed using ADLs, those with
moderate or low ADL scores had a significantly higher deficiency in their ability to manage their
medications by an average of 0.95 points. Participants who reported a fall in the last month or
using an assistive device, had a total deficiency score on MedMaIDE that was significantly higher
(by an average of 1.72 and 0.88 points, respectively) than others who did not. In the adjusted linear
regression model, health literacy, ADLs, and fall were significant predictors for high MedMaIDE
total deficiency scores. Reporting low health literacy or having a fall significantly increased
participants’ inability to manage their medication by more than one point on average. Having
moderate or low ADL function significantly increased the total deficiency score by less than one
point on MedMaIDE (0.83 points).
The final adjusted model was built using all the significant variables from all the previous
models (4 models). The significant predictors that were used to build the final model are
participants’ education level, having asthma, stroke, and/or hearing impairment, having trouble
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reading prescriptions labels and opening prescription bottles, health literacy, ADLs, and falling.
The final adjusted model showed that an education level of high school or less, difficulties reading
prescription labels or opening the medication bottles, and low or inadequate health literacy were
the significant predictors for high deficiency in the medication management capacity. The total
deficiency score of MedMaIDE increased by more than one point on average among those
participants who reported having high school education or less and reported difficulties reading
the prescription labels or opening the medication bottles. The mean total deficincy score of
participants with low health literacy increased by less than one point when compared with
participants who had higher or adequate health literacy (Table 5.12).
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Table 5.8 Unadjusted and Adjusted Linear Regression models of Total MedMaIDE Deficiency
Score and Demographic Characteristics

Age
55 - 64 years old
65 - 74 years old
75 years or older

Unadjusted Model
Parameter
P-Value
Estimate (SE)
0.0774
- 0.45 (0.43)
0.2970
0.74 (0.58)
0.2093

Adjusted Model
Parameter
P- Value
Estimate (SE)
0.1373
- 0.46 (0.42)
0.2729
0.56 (0.42)
0.3157

Sex
Male
Female

0.06 (0.38)

0.8821

Race
White
None white
Marital Status
Ever married
Never married
Educational Level
College degree
Some College
High School/GED
Less than high School
Type of insurance
Other
Medicaid
Medicare
Dual eligible
Living Arrangement
With Other
Alone
Health Status
Excellent/Very good
Good
Fair / Poor

- 0.03 (0.55)
0.39 (0.38)
0.41 (0.71)
1.68 (0.66)
1.46 (0.69)
0.24 (1.26)
0.47 (1.20)
0.82 (1.17)
- 0.81 (1.01)
0.08 (0.48)
- 0.15 (0.48)

0.9530
0.3095
0.3084
0.0123*
0.5658
0.0117*
0.0338*
0.6555
0.8496
0.6934
0.4802
0.4243
0.4236
0.8719
0.8668
0.7474

-0.81 (0.56)

0.50 (0.71)
1.84 (0.69)
1.44 (0.73)

0.1437

0.0114*
0.4841
0.0080*
0.0481*

* Significant P-value < 0.05
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Table 5.9 Unadjusted and Adjusted Linear Regression Models of MeMaIDE Total Deficiency
Score and Comorbidities

Comorbidities
Arthritis
Asthma
COPD or Emphysema
Congestive heart failure
Heart attack (MI)
Stroke or TIA
Peripheral vascular disease
Diabetes types I and II
Upper gastrointestinal disease
Depression
Anxiety or panic disorders
Visual impairment
Hearing impairment
Degenerative disc disease
Obesity and/or BMI > 30
Number of comorbidities

Unadjusted Model
Parameter
P-value
Estimate (SE)
0.11 (0.40)
0.7755
0.67 (0.43)
0.1231
0.25 (0.46)
0.5854
0.21 (0.41)
0.6045
0.22 (0.61)
0.7186
1.04 (0.47) 0.0277*
0.53 (0.47)
0.2507
0.04 (0.41)
0.9173
-0.18 (0.39)
0.6433
0.48 (0.39)
0.2211
0.21 (0.41)
0.6052
0.50 (0.38)
0.1868
0.72 (0.47)
0.1249
-0.49 (0.42)
0.2353
-0.29 (0.39)
0.4531
0.10 (0.07)
0.2029

Adjusted Model
Parameter
P- value
Estimate (SE)
0.86 (0.42)

0.0412*

1.19 (0.46)
0.76 (0.45)
-0.50 (0.40)

0.0101*
0.0919
0.2174

0.57 (0.45)

0.2048

0.90 (0.45)
-0.57 (0.40)
-0.44 (0.38)

0.0464*
0.1564
0.2420

Note: the reference for all comorbidities is “No vs. Yes”, and for the number of comorbidities is “One-Comorbidity
Increase).
* Significant P-value < 0.05
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Table 5.10 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Score and
Medication-Taking Behavior

Variable (reference)

Unadjusted Model
Parameter
P-value
Estimate (SE)

Medication History
Number of meds (1-med increase)
0.09 (0.05)
Number of daily doses (1-dose
0.03 (0.04)
increase)
Medication Regimen Complexity (10.03 (0.02)
score increase)
Medication Adherence Barriers: having trouble with
Reading Rx labels (no-yes)
1.70 (0.45)
Opening Rx bottles (no-yes)
2.22 (0.55)
Refilling meds on time (no-yes)
- 0.68 (0.63)
Paying for meds (no-yes)
- 0.50 (0.51)
Medication Non-adherence
Missing a dose of any meds taken
None
One dose
0.15 (0.54)
Two or more doses
0.18 (0.50)
Ability to take meds as prescribed
Excellent (adherent)
Not Excellent (Not adherent)
0.87 (0.38)

0.0707

Adjusted Model
Parameter
P-value
Estimate (SE)
0.06 (0.04)

0.1550

1.33 (0.42)
1.40 (0.56)
-0.85 (0.56)

0.0017*
0.0118*
0.1308

0.64 (0.36)

0.0711

0.3665
0.2638
0.0001*
<.0001*
0.2814
0.3277
0.9167
0.7864
0.7129
0.0218*

* Significant P-value < 0.05
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Table 5.11 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Deficiency
Score and Geriatric Assessments Variables

Variables
Health literacy
High/adequate health literacy
Low/inadequate health literacy
Cognitive Status (Mini-Cog)
Possible impairment
No impairment
Functional status (ADL)
Highly independent
Moderate/low independent
Fall in the last month (no-yes)
Using assistive devices (no-yes)
Wearing eye-glasses (no-yes)
Depression status (GDS-15)
Normal (≤ 5)
Depression (≥ 5)

Unadjusted Model
Parameter
Estimate
P-value
(SE)
1.50 (0.32)

<.0001*

-0.35 (0.41)

0.4025

0.95 (0.44)
1.72 (0.59)
0.88 (0.37)
-0.46 (0.49)

0.0300*
0.0033*
0.0188*
0.3436

0.24 (0.44)

0.5939

Adjusted Model
Parameter
Estimate
P-value
(SE)
1.39 (0.35)

<.0001*

0.83 (0.40)
1.20 (0.55)

0.0365*
0.0289*

0.53 (0.43)

0.2246

* Significant P-value < 0.05
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Table 5.12 Final Adjusted model of MedMaIDE Total Deficiency Score and Significant Predictors

Variables
Educational Level
College degree
Some College
High School/GED
Less than high School
Comorbidities
Asthma (no-yes)
Stroke or TIA (no-yes)
Hearing impairment (no-yes)
Medication Adherence Barriers
Trouble reading Rx labels (no-yes)
Trouble opening Rx bottles (no-yes)
Health Literacy
High/adequate health literacy
Low/inadequate health literacy
Functional Status (ADL)
Highly independent
Moderate/low independent
Fall in the last month (no-yes)

Adjusted model
Parameter
Estimate
P-value
(SE)
0.0114*
0.50 (0.71)
0.4841
1.84 (0.69) 0.0080*
1.44 (0.73) 0.0481*

Final adjusted model
Parameter
Estimate
P-value
(SE)
0.0405*
0.47 (0.60)
0.4326
1.32 (0.57)
0.0195*
1.24 (0.61)
0.0415*

0.86 (0.42)
1.19 (0.46)
0.90 (0.45)

0.0412*
0.0101*
0.0464

1.33 (0.42)
1.40 (0.56)

0.0017*
0.0118*

1.18 (0.41)
1.43 (0.51)

0.0036*
0.0047*

1.39 (0.35)

<.0001*

0.90 (0.33)

0.0063*

0.83 (0.40)
1.20 (0.55)

0.0365*
0.0289*

0.51 (0.37)
0.80 (0.51)

0.1733
0.1135

* Significant P-value < 0.05
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5.4 Impact of Using Pharmaceutical Aid/Service on MMC
Although there were only 22 (20.56%) participants receiving assistance with medication
from someone, the majority of the participants (79.44%) used at least one pharmaceutical
aid/service. There were 35 (32.71%) participants who used one aid/service, while 50 (46.73%)
participants used more than one aid or pharmacy services. Drug organizers (pillbox) were the most
common medication aid used by the participants (n=47, 43.93%) followed by medication lists or
cards (n=45, 42.06%) and prescription home delivery/mail order (n=32, 29.91%). On the other
hand, only 12 (11.21) participants had someone assist them with ordering their medications (Table
5.4).
Compared to the participants who did not receive assistance with medications, the mean
MedMaIDE total deficiency score was not significantly different among those participant who
received assistance with medication from someone. Likewise, the participants who use
pharmaceutical aid/service had a total deficiency scores that was not significantly different than
others (Table 5.4). However, mean total deficiency scores were significantly higher among the
participants who had someone remind them to take their medications on a regular basis than those
who did not (mean diff = -2.15, 95% CI: -3.77, -0.53). Furthermore, the participants who used
special packaging, like bubble packaging had significantly higher mean total deficiency scores
compared to others who did not use special packaging (mean diff = -1.71, 95% CI: -3.23, -0.19).
The unadjusted models indicated that the mean total deficiency score increased by on
average 0.89 points when participants receiving assistance with medications from someone.
MedMaIDE scores decreased by 0.77 points on average among the participant who used one
pharmaceutical aid or service and by 0.22 in those who used more than one compared to those who
did not use any (Table 5.13). However, none of these associations were statistically significant.
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The adjusted model included the significant predictors from specific aim two (education
level, trouble reading prescription labels, opening medication bottles, and health literacy). In
addition, some other potential predictors such as the number of diseases, medications taken, and
daily doses, medication complexity, and cognitive status were included. The adjusted model
showed that when adjusting for receiving assistance with medication and using pharmaceutical
aids/services, the participants with high total deficiency scores on MedMaIDE had not completed
a college education, used more medications on a regular basis, reported difficulty reading the labels
on their medication vials and opening their medication bottles, and had low health literacy.
Moreover, using one pharmaceutical aids/services significantly decreased the mean total
deficiency scores on MedMaIDE by an average of 0.93 points compared to those who did not use
any (p-value = 0.0285). However, the overall reduction in the total deficiency score among those
using pharmaceutical aids/services was not statistically significant in the adjusted models (Table
5.13). It seems like these might be correlated since individuals tend to start using pharmaceutical
aids because they are having difficulty. The aids may not improve their medication capacity
scores, but they may improve overall adherence.
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Table 5.13 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Deficiency
Score and Using Pharmaceutical Aid/Service
Variables

Receiving assistance with meds
No
Yes
Using pharmaceutical aid/service
Using none
Using one
Using more than
Educational Level
College degree
Some College
High School/GED
Less than high School
Asthma (no-yes)
Stroke or TIA (no-yes)
Hearing impairment (no-yes)
Number of comorbidities (1comorbidity increase)
Number of meds taken (1-med
increase)
Number of daily doses (1-dose
increase)
MRC (1-point increase)
Trouble reading Rx labels (no-yes)
Trouble opening Rx bottles (no-yes)
Health Literacy
High/adequate health literacy
Low/inadequate health literacy
Cognitive status (Mini-Cog)
Possible impairment
No impairment
Functional status (ADLs)
Highly independent
Moderate/low independent
Fall in the last month (no-yes)

Unadjusted Model
Parameter
Estimate
P-value
(SE)

Adjusted Model
Parameter
Estimate
P-value
(SE)

0.89 (0.47)

0.0560

0.24 (0.38)

0.27 (0.58)
1.25 (0.55)
0.99 (0.60)

0.5334
0.0853
0.0285*
0.0764
0.0325*
0.6421
0.0236*
0.0979

-0.77 (0.53)
-0.20 (0.50)

-0.93 (0.42)
-0.76 (0.43)

0.50 (0.71)
1.84 (0.69)
1.44 (0.73)
0.86 (0.42)
1.19 (0.46)
0.90 (0.45)

0.1468
0.6933
0.0114
0.4841
0.0080
0.0481
0.0412
0.0101
0.0464

0.46 (0.37)

0.2180

0.10 (0.07)

0.2029

-0.09 (0.06)

0.1372

0.09 (0.05)

0.0707

0.11 (0.04)

0.0127*

0.03 (0.04)

0.3665

0.03 (0.02)
1.33 (0.42)
1.40 (0.56)

0.2638
0.0017
0.0118

1.11 (0.39)
1.16 (0.50)

0.0047*
0.0198*

1.39 (0.35)

<.0001

0.97 (0.33)

0.0029*

-0.35 (0.41)

0.4025

0.83 (0.40)
1.20 (0.55)

0.0365
0.0289

0.63 (0.37)
0.92 (0.49)

0.0902
0.0632

* Significant P-value < 0.05
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5.5 Association Between MMC and ER Utilization
The rate of the Emergency Room (ER) visits over the last six months was 21.5% (n=23),
however, this might be not sufficient size to test the association between MMC and ER visits.
Among those ER visits, 17 participants (73.91%) reported only one ER visits while six participants
(26.09%) reported more than one ER visits within six months. The most common reasons for those
ER visits were uncontrolled symptoms (15 visits, 65.22%) such as abdominal pain, headache, and
shortness of breath. Only five visits (21.73%) were due to medication-related problems such as
running out of medications and adverse drug reactions. While three (13.05%) of them were due to
other reasons such as a car accident, a suicidal attempt, and falling.
There was no significant difference in demographic characteristics between ER visit groups
except in age and educational level. Reported ER visits were significantly higher among the
participants aged 65 years and older with college or some college education compared with
younger participants with less education levels (Table 5.14). Moreover, having at least one ER
visit was significantly higher among the participants who reported having congestive heart failure,
depression, and anxiety than those who did not. In addition, there was a significant difference in
the mean total number of comorbidities among ER visit groups (Table 5.15). The mean difference
in the total number of comorbidities was 1.55 higher among participants with ER visits compared
to the no ER visit groups (95% CI: -2.85, -0.25).
The MedMaIDE total deficiency score was lower among the participants who reported ER
visits compared to those who did not. The mean difference in the MedMaIDE total deficiency
score was 0.91 (95%CI: 1.97, 0.46, p-value = 0.0536). The sample size might be not sufficient to
examine this association between MMC and ER visits. Furthermore, ER visit groups had a higher
mean number of medications, daily doses taken, as well as medication complexity compared to
the participants in the no ER visits group (Table 5.16). However, none of these differences were
Page 110 of 155

statistically significant. There was no significant difference between the two ER visit groups in
medication-taking behavior variables. Furthermore, geriatric assessments including health
literacy, cognitive and functional status, history of fall, using assistive devices, wearing eyeglasses,
and depression status, were not significantly different among the participants in either ER visit
group (Table 5.17).
The unadjusted logistic regression model indicated that there was no significant association
between medication self-management capacity and ER visits. However, as the total deficiency
score of MedMaIDE increased, the odds of visiting the ER decreased. Moreover, the odds of
reporting ER visits within six months increased among the younger participants who were 55 – 64
years old as well as the participants with college or some college education. Compared to the
participants aged 65 years and older, the odds of reporting ER visits was 2.93 times higher among
the participants aged 55- 64 years. Compared to the participants with high school (or less
education), those with college education (or some college) were 3.07 times more likely to have ER
visits. For every one comorbidity increase, the odds of reporting ER visits increased by 1.20 times
(95% CI: 1.02, 1.41).
The final adjusted model included the potential variables: age, educational level, health
status, total number of comorbidities, medication and daily doses taken, medication regimen
complexity, cognitive and functional status, and having depression symptoms. There was no
significant association between the MedMaIDE total deficiency scores and ER visits, even when
controlling for participants’ age, educational level, and comorbidities. This adjusted model
suggested that for every one-score increase in the total deficiency score, the odds of ER visits
increased by 1.23 times. However, increasing number of comorbidities was the only significant
predictor for reporting ER visits when adjusting for participants’ age educational level, functional
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status, and medication self-management capacity (Table 5.18). The final model fit was evaluated
using the Hosmer and Lemeshow Goodness-of-Fit Test, which indicated that the model had
adequate fit to the data, and did not deviate significantly from the data (Chi-square = 3.54, P-value
= 0.8961).
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Table 5.14 Participants’ Demographic Characteristics by ER Visits

Demographic Characteristics
Age

ER Visits in the last 6 months
None
At least one
N= 84 (78.50)
N= 23 (21.50)
Mean (SD)
Mean (SD)
69.24 (7.47)
66 (5.74)
N (Col %)
N (Col %)

Age
55 - 64 years old
65 years or older

20 (23.81)
64 (76.19)

P-value
0.0566
P-value
0.0245*

11 (47.83)
12 (52.17)
0.3052

Sex
Male
Female

43 (51.19)
41 (48.81)

9 (39.13)
14 (60.87)

10 (11.90)
74 (88.10)

5 (21.74)
18 (78.26)

44 (52.38)
40 (47.62)

13 (56.52)
10 (43.48)

0.3065

Race
White
None white
Marital Status
Ever married
Never married
Educational Level
College degree
Some College
High School/GED
Less than High School
Educational Level
College degree/some
High school or less
Type of insurance
Medicaid
Medicare
Dual eligible
Other
Living Arrangement
Alone
With Other
Health Status
Excellent/Very good
Good
Fair / Poor
Health Status
Excellent/Very good/Good
Fair / Poor

0.7243

0.0013*
3 (3.57)
19 (22.62)
38 (45.24)
24 (28.57)

7 (30.43)
5 (21.74)
4 (17.39)
7 (30.43)

22 (26.19)
62 (73.81)

12 (52.17)
11 (47.83)

11 (13.10)
22 (26.19)
50 (59.52)
1 (1.19)

3 (13.04)
4 (17.39)
14 (60.87)
2 (8.70)

0.0177*

0.2531

1.0000
81 (96.43)
3 (3.57)

22 (95.65)
1 (4.35)

25 (29.76)
31 (36.90)
28 (33.33)

6 (26.09)
6 (26.09)
11 (47.83)

0.4198

0.2007
56 (66.67)
28 (33.33)

12 (52.17)
11 (47.83)

* Significant P-value < 0.05
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Table 5.15 Participants’ Comorbidities by ER Visits

Comorbidities
Arthritis
Osteoporosis
Asthma
COPD, ARDS, or Emphysema
Congestive heart failure
Heart attack
Stroke or TIA
Peripheral vascular disease
Diabetes types I and II
Upper gastrointestinal disease
Depression
Anxiety or panic disorders
Visual impairment
Hearing impairment
Degenerative disc disease
Obesity and/or (BMI) > 30
Number of comorbidities

ER Visits in the last 6 months
None
At least one
N= 84 (78.50)
N= 23 (21.50)
N (Col %)
N (Col %)
49 (58.33)
17 (73.91)
2 (2.38)
3 (13.04)
23 (27.38)
5 (21.74)
16 (19.05)
8 (34.78)
22 (26.19)
12 (52.17)
8 (9.52)
4 (17.39)
15 (17.86)
6 (26.09)
19 (22.62)
4 (17.39)
28 (33.33)
8 (34.78)
37 (44.05)
9 (39.13)
28 (33.33)
13 (56.52)
22 (26.19)
13 (56.52)
39 (46.43)
13 (56.52)
19 (22.62)
3 (13.04)
22 (26.19)
10 (43.48)
36 (42.86)
12 (52.17)
Mean (SD)
Mean (SD)
4.58 (2.64)
6.13 (3.28)

P-value
0.1733
0.0654
0.5855
0.1089
0.0177*
0.2828
0.3786
0.7765
0.8963
0.6730
0.0427*
0.0060*
0.3908
0.3942
0.1086
0.4260
P-value
0.0201*

* Significant P-value < 0.05
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Table 5.16 Medication-Related Variables by ER Visits

MedMaIDE total deficiency score
Number of meds
Number of daily doses
Medication Regimen Complexity
Receiving meds assistance from someone
Yes
No
Using Pharmaceutical aids/services
Using none
Using one
Using more than one
Medication Adherence Barriers
Yes
No
Reading Rx labels
Opening Rx bottles
Refilling meds on time
Paying for meds
Medication Non-adherence
Missing a dose of any meds taken last week
None
One dose
Two or more doses
Ability to take meds as prescribed
Excellent (adherent)
Not Excellent (Not adherent)

ER Visits in the last 6 months
None
At least one
N= 84 (78.50)
N= 23 (21.50)
Mean (SD)
Mean (SD)
3.17 (2.08)
2.26 (1.48)
7.40 (3.97)
8.91 (4.54)
7.80 (5.16)
9.35 (4.84)
13.23 (8.37)
16.59 (9.29)
N (Col %)
N (Col %)
17 (20.24)
67 (79.76)

5 (21.74)
18 (78.26)

18 (21.43)
27 (32.14)
39 (46.43)

4 (17.39)
8 (34.78)
11 (47.83)

35 (41.67)
49 (58.33)
16 (19.05)
13 (15.48)
6 (7.14)
12 (14.29)

12 (52.17)
11 (47.83)
6 (26.09)
0
5 (21.74)
6 (26.09)

P-value
0.0536
0.1207
0.1988
0.0991
P-value
0.8746

0.5270

0.3683

0.4592
0.0662
0.0559
0.1801
0.2983

53 (63.10)
12 (14.29)
19 (22.62)

16 (69.57)
5 (21.74)
2 (8.70)
0.5270

34 (40.48)
50 (59.52)

11 (47.83)
12 (52.17)

* Significant P-value < 0.05
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Table 5.17 Geriatric Assessments Variables by ER visits
ER Visits in the last 6 months
None
At least one
N= 84 (78.50)
N= 23 (21.50)
N (Col %)
N (Col %)
Health Literacy
High/adequate
Low/inadequate
Cognitive Function
Possible impairment
No impairment
Functional Status
Highly independent
Moderate/Low independent
Using Assistive device
Fall
Wearing eyeglasses
Having depression symptoms
Normal (no depression)
Depression symptoms

49 (58.33)
35 (41.67)

P-value
0.5970

12 (52.17)
11 (47.83)
0.1338

29 (34.52)
55 (65.48)

4 (17.39)
19 (82.61)

61 (72.62)
23 (27.38)
46 (54.76)
9 (10.71)
68 (80.95)

20 (86.96)
3 (13.04)
9 (39.13)
3 (13.04)
19 (82.61)

65 (77.38)
19 (22.62)

15 (65.22)
8 (34.78)

0.1822

0.1839
0.7182
1.0000
0.2341

* Significant P-value < 0.05
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Table 5.18 Unadjusted and Adjusted Logistic Regression Models for ER Visits and Potential
Predictors
Unadjusted Model
POR (95 % CI)
Value
MedMaIDE total deficiency
score (1-point increase)
Age
65 years or older
55 - 64 years old
Educational Level
High school or less
College degree/some
Health Status
Excellent/very good/good
Fair/Poor
Number of comorbidities (1comorbidity increase)
Number of meds (1-med
increase)
Number of daily doses (1-dose
increase)
MRC (1-point increase)
Health Literacy
High/adequate
Low/inadequate
Cognitive Function
Possible impairment
No impairment
Functional Status
Moderate/Low indep.
Highly independent
Fall
No
Yes
Having depression symptoms
Normal (no depression)
Depression symptoms

Adjusted Model
OR (95 % CI)

PValue

0.0573

0.81 (0.60, 1.10)

0.1809

2.93 (1.12, 7.66) 0.0280*

2.89 (0.96, 8.66)

0.0583

3.07 (1.19, 7.96) 0.0207*
0.2041
1.83 (0.72, 4.67)

2.59 (0.88, 7.62)

0.0837

1.20 (1.02, 1.41) 0.0253*

1.25 (1.03, 1.52)

0.0219*

0.0926

0.77 (0.58, 1.01)

1.09 (0.98, 1.22)

0.1241

1.06 (0.97, 1.15)

0.2008

1.04 (0.99, 1.10)

0.1025

1.28 (0.51, 3.24)

0.5975

2.50 (0.78, 8.06)

0.1235

2.51 (0.68, 9.27)

0.1662 3.66 (0.81,16.58)

1.25 (0.31, 5.05)

0.7541

1.82 (0.67, 4.95)

0.2380

* Significant P-value < 0.05H
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CHAPTER SIX
DISCUSSION AND CONCLUSION
6.1 Discussion
To the best of our knowledge, this is the first study examining the relationship between
MMC and a wide range of variables among older adults living in the subsidized housing
community. This study adds several findings to the existing literature. First, a resident aged 55
years or older and living in subsidized housing uses on average approximately eight medications
that are associated with about five medical conditions. Second, many low-income older adults have
limited ability to manage their own medications, in particular, they have a lack of knowledge about
their medications. Third, among members of this group, low educational level, low health literacy,
and reporting difficulties reading medication labels or opening medication bottles are significant
risk factors for medication mismanagement. Four, assessing older adults’ ability to manage their
own medication using a standardized tool like MedMaIDE helps to identify those at risk for
medication mismanagement and is useful for individualizing interventions based on their needs
and specific deficiencies.
The study sample was recruited from five subsidized housing communities, and they
represent the common characteristics of the residents of HUD buildings. The study sample was
more likely to live on their own independently with multiple chronic conditions, and were more
likely to have limited educational level and health literacy, and reported fair or poor health status.
The results of this cross-sectional study showed that older adults who live in low-income
housing communities had an average of about three deficiencies in their medication management
capacity as assessed using MedMaIDE. Among 107 participants age 55 years or older, 98 (91.59%)
of them had one or more deficiencies in medication management and 81 (75.70%) had two or more
deficiencies in medication management. These findings are higher than what a previous study
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found using the same assessment tool (Orwig D., et al.).1 The participants of that study were 50
community-dwelling older adults with an average age of 78.18 (±7.21) and about 9.38 (±3.74)
years of education, and their annual income ranged from $9,000 to 12,000.1 In that study, the mean
total deficiency score was approximately two (±1.96), and 70% had one or more deficiencies in
medication management on MedMaIDE.1 Specifically, the sub-score for the first area was 2.17
(±1.55) in our study, which is almost double what was found in the previous study [1.46 (±1.54)].
These high overall scores might be due to relying on the written directions on the labels to compare
to what the participants reported when assessing their knowledge about medications.1 As a result,
one point (unable) was given for any discrepancies that occurred between what was reported by
the participant and what was written on the labels during the assessment of MMC. Nevertheless,
credits were given for any appropriate answer reported by the participants when the indication was
not specified on the labels and the medication had multiple indications. This may increase the subscore for the first area as well as the overall score. Furthermore, the most difficult skill was naming
the medications followed by stating the indication, timing, frequency, and identifying existing
refills. These findings are consistent with the previous study. However, the participants in that
study were older than this study (78.18 vs. 68.54 years). The sample in both studies was highly
independent, cognitively intact, and used a high number of prescription medications on average
(approximately ≥ 7 medications on average). Unfortunately, we cannot compare our findings with
the other studies using MedMaIDE to assess the deficiencies in medication management because
the participants were caregivers.2,3
The analysis of this study shows that low educational level, reporting difficulties reading
the medication labels or opening the medication bottles, and low or inadequate health literacy are
strong independent predictors for low medication self-management capacity among low-income
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older adults. These predictors remained significant even after adjusting for all other significant
predictors in one model.
We found a robust association between participants’ ability to self-manage their
medications and educational level. Participants with less than or equal to high school education
had a significantly higher deficiency in their ability to manage medications compared to those with
a college education or more. While numerous studies describe the association between educational
level and medication management, the findings are inconsistent.4–8 One of the previous studies
showed that the odds of being unable to identify all medications increased 3 times among patients
with less than 12 years of schooling.4,5 The negative association was seen in the studies that
included a well-educated sample.4 In contrast, about 68.22% of our sample had less than or equal
to high school education which can be used as an indicator of living in low socioeconomic status
(SES). Therefore, our findings may support evidence that has found that low socioeconomic status
is a risk factor for medication mismanagement.7,8 Also, it is consistent with the idea that education
level is a social determinant of health.9
Consistent with the literature, our findings showed that low/inadequate health literacy was
significantly related to low MMC. An observational study found that patients with inadequate
health literacy were 18 times more likely to be unable to identify all of their medications compared
to patients with adequate health literacy.4 Furthermore, other studies have shown that patients with
low health literacy are unable to understand medication instruction easily.10,11 In a published
survey for Medicare managed care enrollees, 47.5% of respondents with inadequate health literacy
were unable to identify the appropriate timing of the dose that was written on the labels, and 54.3%
inadequate-literacy respondents struggled to explain how to take a medication on an empty
stomach.11 These findings in combination with our study findings indicate that low health literacy
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may impact an individual’s cognitive ability to manage medications. Consequently, health care
providers, in particular pharmacists, should consider the patients’ level of education, health
literacy, and SES when providing education about medication use.
In this study, the association between the deficiency in medication management capacity
and self-reported medication adherence was statistically significant only in the bivariate analysis.
Reporting trouble reading labels and opening medication bottles was significantly related to the
deficiency in MMC in both bivariate and multivariate analysis. We found that the participants who
reported trouble reading labels or opening medication bottles had a higher total deficiency score
by more than one point on average compared to others who did not report these medication-related
difficulties. In the literature, there has been a conflict regarding the correlation between MMC and
both objectively measured and self-reported medication adherence1,8,12,13 The validation study of
MedMaIDE showed that as the deficiency in medication management increases, the medication
adherence (based on 30-day pill count) decreases.1 Other studies concluded that patients’ capacity
to manage meditations does not significantly impact their adherence status. The developers (Murry
et al.) of the medication assessment instrument (MAI), one of the MMC assessment tools, reported
a significant association between medication adherence and two skills of medication management
among community-dwelling older adults.12 These two skills were inability/difficulty to open a flip
top lid and read a medication label.12 Even though it is not entirely clear why this relationship
exists, it could be due to the low educational level, visual impairment, having arthritis or any other
factors. This finding indicates that the pharmacist should check older adult patients’ ability to read
the details on the label and remove the cap on the medication vials before leaving the pharmacy.
Thereafter, further investigation should be done to identify the appropriate intervention. Older
adult patients who live alone are at risk for medication errors when they cannot read the directions
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on the label or cannot open child-resistant caps. In addition, they may lack assistance with
medication at home which may put them at higher risk of medication errors. Therefore, the
directions on the label of all medications, not just newly prescribed medication, should be reviewed
with elderly patients before leaving the physicians office and/or pharmacy. In addition, the
information about the availability of non-child resistant caps and other medication packaging
should be provided to older adult patients.
The findings of this study suggested that the association between MMC and the number of
comorbidities did not exist. This is consistent with what has been reported in existing literature.5,7
However, we found that specific comorbidities like asthma, stroke and hearing impairment are
positive predictors for deficiency in medication management when adjusting for other
comorbidities and number of comorbidities. In general, stroke may contribute to cognitive and
physical impairments, and arthritis contributes to dexterity issues among older adult patients. In
addition, patients with asthma and stroke are typically prescribed complicated and multiple
medication regimens.14 However, our findings indicated that there was a non-significant
relationship between limited medication management capacity and taking a high number of
medications and daily doses taken, and complicated medication regimens. These findings are
consistent with what has been reported previously.5,7,8,15 Therefore, the limited MMC among
patients with asthma and stroke might not be related to using multiple and complex medication
regimens. Furthermore, a cross-sectional study observed that using hearing aids does not impact
older adults’ ability to take oral medication.7 Another study showed that lacking the knowledge
and skills to manage heart failure medications are related to negative health outcomes.16
On the bivariate analyses, we observed that limited ability to perform basic ADLs, using
assistive devices, and a history of falling are positive predictors for deficiency in medication
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management capacity. However, this was not the case in the multivariate analysis. The MedMaIDE
validation study found that self-reported ADLs and IADLs were not significantly related to the
sample’s ability to manage their medication, similar to what has been reported in other studies. 1,5
However, a one year follow up study confirmed a significant relation between MMC and both selfreported ADLs and IADLs after six months.15
Unlike other studies, this study failed to observe the significant relationship between MMC
and participants’ cognitive function.1,4,5,7,8,15 This inconsistent finding with other studies might be
due to two reasons. First, the Mini-Cog was used in this study to assess cognitive function, while
most of the previous studies used the Mini-Mental State Examination (MMSE). Second, the
sample in this study was relatively cognitively intact. The participants who had Alzheimer’s
disease, dementia, or were taking any medications for memory (such as cholinesterase inhibitors
and memantine) were excluded. Moreover, a cross-sectional study concluded that the Mini-Cog is
a significant screening tool for determining patients’ ability to organize a pillbox. The findings of
that study showed a weak correlation between MMSE and ability to organize the pillbox.17 Another
study concluded that impaired concentration and poor visual and verbal memory were predictive
of poor medication planning ability, while limited motor dexterity and strength was an indicator
of inability to open the child-resistant cap and cutting pills.18
Even though the MMSE covers more aspects of cognitive function ─ including orientation,
word registration, attention and calculation, recall, and language ─ it fails to detect people with
deficiency in executive cognitive function (ECF). Moreover, individual’s age, educational level,
literacy, SES, and language affect MMSE scores.19,20 Consequently, older adults who have a low
educational level or SES, and limited communication skills may score poorly on the MMSE even
when they are cognitively intact.20,21 On the other hand, the clock drawing test component of the
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Mini-Cog assessment is specifically designed to assess ECF. Additionally, scoring on the MiniCog is not related to age, educational level, or language.19,20 Since managing a medication regimen
appropriately requires coordination of simple tasks, like identifying the medication, opening and
removing the medication from packaging and recalling the dosing time and frequency, it mainly
depends on an individual’s ECF.21 Therefore, Mini-Cog might be the appropriate screening tool
to identify people with the required cognitive function to self-manage their medication
independently.
Consistent with the literature, older adults’ cognitive and functional ability to manage their
medication was not influenced by depression symptoms as measured by the GDS.5,7,15 In addition,
we did not observe a difference in medication management among the participants who were
diagnosed with depression or anxiety.
When the residents had someone reminding them to take medication on regular basis, more
deficiency in medication management was observed than those who did not have assistance
(MedMaIDE total score: 5.00 (±2.45) vs. 2.85 (±1.68), p-value = 0.0098). In addition, using bubble
pack packaging was related to a higher deficiency in medication management (4.57 (±2.44) vs.
2.86 (±1.93), p-value = 0.0277). A study reported patients who were using blister pack and
receiving reminders from someone to take medications were more likely to have limited ability to
recall medication instructions.22 When individuals have trouble with medication management are
often offered specialized packaging like bubble pack as a way to help them. Using specialized
packaging may not necessarily improve their knowledge about medications but it helps keeping
them on schedule. However, the packages may or may not be easier to open depending on the
packaging system. In this case, maybe the poor capacity is the cause of getting packaging.
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Therefore, it helps to improve adherence, but not necessarily by increasing their capacity to
manage medications especially concerning knowledge of their medications.
As expected, the findings of this study suggest that using pillbox organization increased
older adults’ ability to manage their medication. Even though pillbox (43.93%) was the most
common medication aid used by the participants, the relationship between MMC and using a
medication organizer aid was not statistically significant. This might be explained by participant
difficulty organizing or refilling the pillbox, an item that was not captured using MeMaIDE. Even
though MedMaIDE was designed to assess patients’ ability to manage different dosage forms, it
does not asses their ability to organize or fill the pillbox. A cross-sectional study concluded that
patients' cognitive ability to comprehend prescriptions impacts their ability to correctly organize
and fill the pillbox. This study proposed a new tool (Medi-Cog) as a screening for determining
pillbox organization ability and identifying patients at risk for medication mismanagement.17
In our study, limited MMC was observed when the participants reported assistance with
medications from someone (i.e. reminding them to take medication, setting up the pillbox, or
ordering there refills). While, high MMC was observed among the participants who used
medication aids (i.e. drug list/card, organizer, or reminder) or pharmacy services (i.e. special
packaging, non-child-resistant cap, prescription home delivery, or mail order). However, these
observations were not statistically significant even when adjusted for other significant predictors
for self-managing of medications. In the adjusted model, taking a high number of medications
turned out to be as a positive predictor for deficiency in medication management along with low
educational level, reporting difficulties reading labels and opening bottles, and limited health
literacy when adjusted for receiving assistance with medication and using medication aids or
pharmacy services. However, the literature suggests that using medication aids and medication
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synchronization programs can improve medication adherence.23,24 Indeed, using at least one
pharmaceutical aids/services might correlate with low MMC since individuals tend to start
receiving help or using pharmaceutical aids because they are having difficulty. The aids and
assistance with medication may not improve their medication capacity scores, but they may
improve overall adherence.
This study shed light on the issue of emergency room utilization among the study sample.
Since 2012, when RHWP clinics were implemented, the overall rates of ER visits have
decreased.25 Despite this fact, there were 23 (21.50%) participants who reported ER visits within
six months before the study interview. The findings suggest that age, educational level, and number
of comorbidities are significantly associated with ER visits among the study sample. Although the
association between ER visits and deficiency in medication management was not significant, we
observed that the deficiency in medication management capacity was higher among the
participants who reported ER visits compared to those who did not. In addition, an ordinal logistic
regression model was conducted as a sensitivity analysis to examine whether the deficiency in
MMC increased the number of ER visits. The ER visits were categorized into three groups: 1) no
ER visits [84 (78.50%)], 2) one ER visit [17 (15.89%)], and 3) more than one ER visits [6 (5.61%)].
The finding of this ordinal logistic analysis showed that the association between MMC and number
of ER visits was not statistically significant [OR = 0.782 (95% CI: 0.598, 1.023), P-value =
0.0723]. This finding is not different than that of the logistic regression analysis (ER visit vs. no
ER visit), which also found no significant difference. This may be because there is no true
association between medication management capacity and ER visits or that there was insufficient
sample size to detect a true difference (Type II error)
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In contrast, a one-year follow-up study reported that the change in MMC between baseline
and six months was significantly related to an increased number of ER visits.15 Another 6-month
follow up study concluded that having limited medication knowledge was significantly associated
with more ER visits among patients 50 years and older with congestive heart failure.16
In our study, ER visits were assessed retrospectively, which might not be as accurate as
other studies that followed patients prospectively. The nature of self-reported data coupled with
the recall period of six months might be factors that affected the accuracy of the reported number.
Even though six months seems like a reasonable period for an average healthy person to recall, it
was clear to the study investigator how difficult it was for some of the participants to recall the
information. A study that looked at the accuracy of self-reported data of health services utilization
among older adults who were 65 years concluded that the health services use were under-reported
by those older adults.26 The finding of that study found that 28.1% of older adults who were 65
years and older failed to report ER visits over 12 months when compared with electronic record
data.26 Another justification for our findings is that the vast majority of the participants were
receiving care from RHWP clinics. Typically, the RHWP team provide a follow-up visit at home
or at clinic for those participants who reported ER visits. During this follow-up visit, the
interprofessional team works with residents to identify any care coordination needs, whether they
are medication or health-related needs. Thereafter, the team works with the resident to fulfill
his/her needs, such as providing medication reconciliation, education/counseling about
medications or health conditions, disease monitoring, or accessing prescription medications or
healthcare services.25 As a result, those participants with ER visits might be scored low on
MedMaIDE which indicates having a high ability to manage their medications independently.
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6.2 Study Limitations
To the best of our knowledge, this is the first study examining the relationship between
MMC and a wide range of variables among older adults living in the subsidized housing
community. This study has several limitations. First, the study sample size was relatively small,
which may lead to a type II error. Therefore, this study has low power to detect the significant
relationship between MMC and some variables. This study intended to study a minority population
of older adults who live in the low-income housing community, and 107 participants have
successfully completed the study. We were fortunate to have complete data without any missing
variables, which increases the study power, despite the small sample size. Further, four separate
models were conducted to identify the significant predictors of limited MMC to address the sample
size issue.
Using a non-probability (non-random) sampling strategy may lead to limited
generalizability and selection bias due to homogeneity among the sample characteristics.
Therefore, the findings cannot be generalized to all community-dwelling older adults. The eligible
age was 55 years or older which may not represent the common chronological age classification
for older adults in developed countries like the U.S. The sample was recruited from five subsidized
housing locations in downtown Richmond VA, which serve a predominately vulnerable older adult
population who lives with a high burden of chronic diseases coupled with economic challenges
and limited access to health resources. By setting this age criterion, we considered the
biological/physiological age which is influenced by various factors such as lifestyle, chronic
diseases, genetics, alcohol consumption, SES, and living location.27 The participants' average age
was about 68 years, and most were African American (83%) with high school or less education,
and living with about five medical conditions. Surprisingly, there was an almost equal proportion
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of male and female participants (48.60 vs. 51.40%, respectively), which may be considered a
strength for this study. The characteristics of this study’ sample were similar to the characteristics
of participants in RHWP clinics. Despite our limitations, research in this minority high-risk
community is needed and may inform future intervention to improve medication self-management
and increase independence. In addition, most of our findings were consistent with previous studies
of MMC performed in different settings.
Another study limitation is that the nature of the study data might introduce some biases to
the findings. Self-reported data may be subject to social desirability and recall bias. Furthermore,
there might be a selection bias due to using a self-selected sample. This sample included mostly
people with a greater interest in taking medication safely and as prescribed, which might not
represent the attitudes or behaviors of the general demographic. During the assessment of MMC,
we relied on the participants to display and report all medications they were using on regular basis
and on the written directions on the labels of these medications to determine their ability to manage
medications. Unfortunately, we do not have access to the residents’ medical record or pharmacy
records, so we may over or underestimate the sample’s MMC. However, we were able to assess
older adults’ medication knowledge for both prescription and OTC medications. We observed a
high deficiency in medication management among the study sample. This was somewhat
surprising because most of the participants were receiving care coordination services from the
RHWP clinics. In addition, participants’ medical history was assessed using the functional
comorbidity index which includes only 18 self-reported medical conditions. Thus, we missed
many chronic conditions/disease that participants might have had that were not included in an
index designed to predict functional impairment.
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In this study, MedMaIDE was chosen over a wide number of validated tools that were
designed to assess MMC for several reasons. One of these reasons is that it evaluates older adults’
cognitive and functional abilities to administer/take different dosage forms, not only oral
medications. However, it does not assess the ability to organize or fill medication organizers such
as pillboxes, which is one of the study limitations. Pillboxes are the most common medication
organization tool used by about 10 million older adults.17 Therefore, further study is needed to
investigate the older adult’s ability to use a pillbox correctly using an appropriate assessment tool.
Additionally, MedMaIDE might be subject to floor or ceiling effects which occurs when most of
the participants are scored near the minimum or maximum score.28 However, the total deficiency
score on MedMaID was normally distributed with a minimum score of 0 and maximum score of
10. Moreover, MedMaIDE is a performance-based tool using the patient’s own medication. Most
of the residents were very collaborative and they brought all medications for review, while a few
of them forgot or decided to bring only some of them. Refrigerated medications (heat sensitive)
like insulin and controlled medications were the most often forgotten or not brought medications
for review.
There was a potential for interviewer bias and measurement bias. However, these types of
bias cannot be completely excluded. All the interviews were conducted and the data were collected
by one interviewer, which may control the interviewer bias and minimize the variance in the data.
The interview procedure and the assessment order was specified in the study protocol, and all the
study assessments were selected based on validity and reliability data.
The last limitation is that the study findings may be influenced by other potential
combinations of mediators or moderators that should be controlled. For example, we assume all
study participants have low socioeconomic status since the participants met certain celling income
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criteria for residing in subsidized housing. Whereas financial/income information may determine
the optimal socioeconomic level, this information is sensitive and not easily obtained as well as
may be difficult to interpret. As a result, the study findings might be interpreted differently by
controlling those potential mediators or moderators.
6.3 Future Direction
A number of observational studies have been done in this area of medication selfmanagement, however, most of them were limited to small sample sizes, and had generalizability
limitations. Future research should be directed toward prospective and interventional studies for a
larger sample size with a more diverse population. The stronger study design would be randomized
prospective cohort study. It would be worthwhile to use a random sampling strategy with a
comparison (control) group to overcome the issues of limited generalizability and selection bias.
We could randomly select a cohort sample of older adults from nationally representative registry
data such as HUDs or Medicare data.
By following up the participants prospectively, we could understand how the cognitive and
functional ability to appropriately manage medications changes over time. It would be important
to study how age-related changes in cognitive and functional status affect the ability to manage
medication independently over time. The power of our study was insufficient to determine the
relationship between MMC and ER visits. The prospective study design will be more appropriate
to examine the relationship between patients’ ability to manage medications and clinical outcomes
such as hospitalization, ER visits, and institutionalization. Furthermore, we could study the
association between MMC and medication outcomes such as medication errors, and medication
adherence. It would be interesting to determine the patients’ ability to manage medications using
two different standardized assessment tools, one of them using the patients’ own medications and
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the another using simulated mediations. In addition, a future study could identify the required skills
and the potential predictors for limited ability to manage pillbox.
This study found that people with low MMC were more likely to start using medication
aids or pharmaceutical services which might improve overall adherence but not necessarily
improve the ability to manage medications. It would be worthwhile to look at the causal
relationship in future studies where MMC would be compared before and after intervention with
pharmaceutical services or RHWP clinic visits. By conducting this experimental design we could
test the hypothesis of whether or not implementing medication interventions would improve a
patient's ability to take medications as prescribed. As a result, the role of using a different types of
medication intervention would be studied including the use of pillbox otherwise specialized
packaging, prescription home delivery, medication regimen simplification and medication
counseling. Also, the effectiveness of implementing medication intervention as identified after
MMC assessments would be determined. Future research in RHWP should examine whether
medication self-management capacity could predict who might not be able to remain living
independently safely or who might need additional support to remain independent. This line of
research would strengthen the evidence on the utility of using a standardized validated tool to
assess MMC in outpatient settings. The effect of potential mediators and moderators should be
considered and controlled in the future study.
Clinical Implications
The findings of this study would be used to improve the effectiveness of clinical
assessments that used in RHWP clinics to identify residents' health deficits and determine their
needs. Medication management is a basic self-care activity, and inclusion of MMC assessment in
comprehensive geriatric assessments is recommended to promote safe use of medications among
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older adults living independently in low-income senior housing. In this study, the association
between low MMC and low educational level and health literacy was statistically significant.
Therefore, screening for health literacy might be a useful clinical assessment to identify those older
adult residents who should get MMC assessment. The findings showed that the three health literacy
questions that were used could be a good screening tool. Additionally, questioning the participants
at RHWP about whether or not they have difficulty opening and reading prescription medications
can be used to determine those who need a full MMC assessment. Assessing MMC using a
standardized and validated tool helps to detect the cognitive and functional limitation in medication
management and target intervention based on needs.
6.4 Conclusion
Many older adult residents of low-income housing communities have deficient capacity to
manage their medications independently. Insufficient medication knowledge is more prevalent
among low-income older adults. Low educational level and health literacy and reporting difficulty
reading the prescription labels and opening the medication bottles are contributing factors to
mediation mismanagement. This present study adds to the growing body of evidence suggesting
that assessing older adults’ ability to manage their own medications using a performance-based
tool such as MedMaIDE may help to identify those individuals with limited medication
management capacity and lead to individualized intervention thereafter. Healthcare providers, in
particular pharmacists, should consider assessing older adults’ capacity for self-managing
medication to identify key targets for interventions, which will promote healthy aging in-place and
independence by enhancing the safe use of medications. There is a need for additional research
studying the change in MMC over a long period of time among a larger sample. It would also be
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useful to study intervention strategies that may improve medication management skills such as
specialized packaging, pillbox organization, improved labeling, and counseling.
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